Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (original) (raw)

Author information

Author notes

  1. These authors contributed equally: Eva G. Alvarez, Adrian Baez-Ortega, Jorge Zamora, Fran Supek.
  2. These authors jointly supervised this work: Peter J. Campbell, Jose M. C. Tubio.
  3. A full list of members and their affiliations appears online.

Authors and Affiliations

  1. Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
    Bernardo Rodriguez-Martin, Eva G. Alvarez, Jorge Zamora, Martin Santamarina, Javier Temes, Alicia L. Bruzos, Sonia Zumalave, Eva G. Alvarez, Bernardo Rodriguez-Martin, Jose M. C. Tubio, Jorge Zamora & Jose M. C. Tubio
  2. Biomedical Research Centre (CINBIO), University of Vigo, Vigo, Spain
    Bernardo Rodriguez-Martin, Eva G. Alvarez, Martin Santamarina, Harald Detering, Alicia L. Bruzos, Eva G. Alvarez, Bernardo Rodriguez-Martin, Jose M. C. Tubio & Jose M. C. Tubio
  3. Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
    Bernardo Rodriguez-Martin, Eva G. Alvarez, Jorge Zamora, Javier Temes, Eva G. Alvarez, Bernardo Rodriguez-Martin, Jose M. C. Tubio, Jorge Zamora & Jose M. C. Tubio
  4. Transmissible Cancer Group, Department of Veterinary Medicine, University of Cambridge, Cambridge, UK
    Adrian Baez-Ortega & Adrian Baez-Ortega
  5. The Biomedical Research Centre (CINBIO), Universidade de Vigo, Vigo, Spain
    Jorge Zamora, Marta Tojo & Jorge Zamora
  6. Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
    Jorge Zamora, Yilong Li, Nicola D. Roberts, Iñigo Martincorena, Peter J. Campbell, Young Seok Ju, Yilong Li, Iñigo Martincorena, Nicola D. Roberts, Jorge Zamora & Peter J. Campbell
  7. Genome Data Science, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
    Fran Supek
  8. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
    Fran Supek, David Torrents & David Torrents
  9. The Francis Crick Institute, London, UK
    Jonas Demeulemeester, Stefan C. Dentro & Peter Van Loo
  10. Department of Human Genetics, University of Leuven, Leuven, Belgium
    Jonas Demeulemeester & Peter Van Loo
  11. Genomes and Disease, Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
    Martin Santamarina, Daniel Garcia-Souto, Jorge Rodriguez-Castro, Alicia L. Bruzos & Sonia Zumalave
  12. Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, South Korea
    Young Seok Ju
  13. Cancer Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Cambridge, UK
    Young Seok Ju, Keiran M. Raine, Adam Butler, Francesco Maura, David C. Wedge, Jose M. C. Tubio & Jose M. C. Tubio
  14. Department of Biochemistry, Genetics and Immunology, University of Vigo, Vigo, Spain
    Harald Detering & Marta Tojo
  15. Galicia Sur Health Research Institute, Vigo, Spain
    Harald Detering
  16. Faculty of Science and Technology, University of Vic—Central University of Catalonia (UVic-UCC), Vic, Spain
    Ana Dueso-Barroso & Ana Dueso-Barroso
  17. Barcelona Supercomputing Center (BSC), Barcelona, Spain
    Ana Dueso-Barroso, Montserrat Puiggròs, David Torrents, Ana Dueso-Barroso, J. Lynn Fink, Montserrat Puiggròs, David Torrents & Izar Villasante
  18. Experimental Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK
    Stefan C. Dentro & David C. Wedge
  19. Oxford Big Data Institute, University of Oxford, Oxford, UK
    Stefan C. Dentro
  20. DNA Repair and Genome Integrity, Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
    Miguel G. Blanco
  21. Department of Biochemistry and Molecular Biology, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
    Miguel G. Blanco
  22. Medical Research Council (MRC) Cancer Unit, University of Cambridge, Cambridge, UK
    Gianmarco Contino & Rebecca C. Fitzgerald
  23. Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Baltimore, MD, USA
    Daniel Ardeljan & Haig H. Kazazian
  24. University of Cambridge, Cambridge, UK
    Paul A. Edwards, Paul A. Edwards, Andy G. Lynch & Florian Markowetz
  25. Li Ka Shing Centre, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
    Paul A. Edwards & Paul A. Edwards
  26. European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany
    Joachim Weischenfeldt, Sebastian M. Waszak, Jan O. Korbel, Jan O. Korbel & Joachim Weischenfeldt
  27. Finsen Laboratory and Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    Joachim Weischenfeldt, Nikos Sidiropoulos & Joachim Weischenfeldt
  28. Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany
    Joachim Weischenfeldt & Joachim Weischenfeldt
  29. Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Zechen Chong
  30. Department of Genetics and Informatics Institute, University of Alabama at Birmingham (UAB) School of Medicine, Birmingham, AL, USA
    Zechen Chong
  31. University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ken Chen, Kadir C. Akdemir & Ken Chen
  32. Division of Genetics and Genomics, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
    Eunjung Alice Lee & Eunjung Alice Lee
  33. The Broad Institute of Harvard and MIT, Cambridge, MA, USA
    Jeremiah A. Wala, Steven E. Schumacher, Rameen Beroukhim, Rameen Beroukhim, Steven E. Schumacher & Jeremiah A. Wala
  34. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA
    Jeremiah A. Wala, Steven E. Schumacher, Steven E. Schumacher & Jeremiah A. Wala
  35. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
    Jeremiah A. Wala, Steven E. Schumacher, Rameen Beroukhim, Rameen Beroukhim, Steven E. Schumacher & Jeremiah A. Wala
  36. Harvard Medical School, Boston, MA, USA
    Jeremiah A. Wala, Rameen Beroukhim, Rameen Beroukhim, Matthew Meyerson, Jeremiah A. Wala & Cheng-Zhong Zhang
  37. Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA
    Fabio C. P. Navarro, Mark Gerstein, Mark Gerstein & Fabio C. P. Navarro
  38. Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA
    Fabio C. P. Navarro, Mark Gerstein, Mark Gerstein & Fabio C. P. Navarro
  39. Department of Computer Science, Yale University, New Haven, CT, USA
    Fabio C. P. Navarro, Mark Gerstein, Mark Gerstein & Fabio C. P. Navarro
  40. Department of Human Genetics, McGill University, Montreal, Québec, Canada
    Jean Monlong
  41. Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy
    Francesco Maura & Niccolo Bolli
  42. Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Francesco Maura & Niccolo Bolli
  43. Canadian Center for Computational Genomics, McGill University, Montreal, Quebec, Canada
    Guillaume Bourque
  44. Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA
    Peter J. Park, Isidro Cortés-Ciriano, Jake June-Koo Lee & Peter J. Park
  45. Ludwig Center at Harvard, Boston, MA, USA
    Peter J. Park, Jake June-Koo Lee & Peter J. Park
  46. Oxford NIHR Biomedical Research Centre, Oxford, UK
    David C. Wedge
  47. European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK
    Jan O. Korbel & Jan O. Korbel
  48. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Baltimore, MD, USA
    Kathleen H. Burns & Kathleen H. Burns
  49. McKusick-Nathans Institute of Genetic Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Kathleen H. Burns & Kathleen H. Burns
  50. Department of Haematology, University of Cambridge, Cambridge, UK
    Peter J. Campbell & Peter J. Campbell
  51. Computational Biology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada
    Paul C. Boutros
  52. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
    Paul C. Boutros
  53. Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
    Paul C. Boutros
  54. University of California Los Angeles, Los Angeles, CA, USA
    Paul C. Boutros
  55. Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    David D. L. Bowtell, Dariush Etemadmoghadam & Dale W. Garsed
  56. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
    David D. L. Bowtell
  57. Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Benedikt Brors & Barbara Hutter
  58. National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany
    Benedikt Brors, Lars Feuerbach & Lina Sieverling
  59. Johns Hopkins School of Medicine, Baltimore, MD, USA
    Benedikt Brors
  60. Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Kin Chan
  61. Centre for Molecular Science Informatics, Department of Chemistry, University of Cambridge, Cambridge, UK
    Isidro Cortés-Ciriano
  62. Ludwig Center, Harvard Medical School, Boston, MA, USA
    Isidro Cortés-Ciriano
  63. Broad Institute of MIT and Harvard, Cambridge, MA, USA
    Andrew J. Dunford, Julian M. Hess, Kiran Kumar, Matthew Meyerson, Chip Stewart & Cheng-Zhong Zhang
  64. Sidra Medicine, Doha, Qatar
    Xavier Estivill & Mark Shackleton
  65. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia
    Dariush Etemadmoghadam & Dale W. Garsed
  66. Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland, Australia
    J. Lynn Fink
  67. The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
    Milana Frenkel-Morgenstern
  68. Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA
    Dmitry A. Gordenin
  69. Biomolecular Engineering Department, University of California, Santa Cruz, Santa Cruz, CA, USA
    David Haan
  70. Brandeis University, Waltham, MA, USA
    James E. Haber
  71. Massachusetts General Hospital Center for Cancer Research, Charlestown, MA, USA
    Julian M. Hess
  72. German Cancer Consortium (DKTK), Heidelberg, Germany
    Barbara Hutter
  73. Heidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg, Germany
    Barbara Hutter & Xiaotong Yao
  74. New York Genome Center, New York, NY, USA
    Marcin Imielinski
  75. Weill Cornell Medicine, New York, NY, USA
    Marcin Imielinski
  76. Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany
    David T. W. Jones
  77. Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
    David T. W. Jones
  78. Korea Advanced Institute of Science and Technology, Daejeon, South Korea
    Young Seok Ju
  79. Skolkovo Institute of Science and Technology, Moscow, Russia
    Marat D. Kazanov
  80. A. A. Kharkevich Institute of Information Transmission Problems, Moscow, Russia
    Marat D. Kazanov
  81. Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia
    Marat D. Kazanov
  82. Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA
    Leszek J. Klimczak
  83. Center For Medical Innovation, Seoul National University Hospital, Seoul, South Korea
    Youngil Koh & Sung-Soo Yoon
  84. Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
    Youngil Koh
  85. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
    Andy G. Lynch, Geoff Macintyre & Florian Markowetz
  86. School of Medicine, University of St Andrews, St Andrews, UK
    Andy G. Lynch
  87. School of Mathematics and Statistics, University of St Andrews, St Andrews, UK
    Andy G. Lynch
  88. Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA
    Alexander Martinez-Fundichely
  89. Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA
    Alexander Martinez-Fundichely
  90. Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
    Alexander Martinez-Fundichely & Cheng-Zhong Zhang
  91. Dana-Farber Cancer Institute, Boston, MA, USA
    Matthew Meyerson
  92. Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland
    Matthew Meyerson
  93. Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia
    Matthew Meyerson
  94. The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
    Satoru Miyano
  95. RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
    Hidewaki Nakagawa
  96. Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
    Stephan Ossowski
  97. Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany
    Stephan Ossowski
  98. Universitat Pompeu Fabra (UPF), Barcelona, Spain
    Stephan Ossowski & Nicola Waddell
  99. Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia
    John V. Pearson & Nicola Waddell
  100. Institute for Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Queensland, Australia
    John V. Pearson
  101. German Cancer Research Center (DKFZ), Heidelberg, Germany
    Karsten Rippe
  102. School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA, USA
    Steven A. Roberts
  103. Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Ralph Scully
  104. Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia
    Mark Shackleton
  105. Faculty of Biosciences, Heidelberg University, Heidelberg, Germany
    Lina Sieverling
  106. Ben May Department for Cancer Research, Department of Human Genetics, The University of Chicago, Chicago, IL, USA
    Lixing Yang
  107. Tri-institutional PhD Program of Computational Biology and Medicine, Weill Cornell Medicine, New York, NY, USA
    Xiaotong Yao
  108. Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland
    Lauri A. Aaltonen
  109. Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
    Federico Abascal, David J. Adams, Ludmil B. Alexandrov, Sam Behjati, Shriram G. Bhosle, David T. Bowen, Adam P. Butler, Peter J. Campbell, Peter Clapham, Helen Davies, Kevin J. Dawson, Stefan C. Dentro, Serge Serge, Erik Garrison, Mohammed Ghori, Dominik Glodzik, Jonathan Hinton, David R. Jones, Young Seok Ju, Stian Knappskog, Barbara Kremeyer, Henry Lee-Six, Daniel A. Leongamornlert, Yilong Li, Sancha Martin, Iñigo Martincorena, Ultan McDermott, Andrew Menzies, Thomas J. Mitchell, Sandro Morganella, Jyoti Nangalia, Jonathan Nicholson, Serena Nik-Zainal, Sarah O’Meara, Elli Papaemmanuil, Keiran M. Raine, Manasa Ramakrishna, Kamna Ramakrishnan, Nicola D. Roberts, Rebecca Shepherd, Lucy Stebbings, Michael R. Stratton, Maxime Tarabichi, Jon W. Teague, Ignacio Vázquez-García, David C. Wedge, Lucy Yates, Jorge Zamora & Xueqing Zou
  110. Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Adam Abeshouse, Hikmat Al-Ahmadie, Gunes Gundem, Zachary Heins, Jason Huse, Douglas A. Levine, Eric Minwei Liu & Angelica Ochoa
  111. Genome Science Division, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan
    Hiroyuki Aburatani, Genta Nagae, Akihiro Suzuki, Kenji Tatsuno & Shogo Yamamoto
  112. Department of Surgery, University of Chicago, Chicago, IL, USA
    Nishant Agrawal
  113. Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, School of Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea
    Keun Soo Ahn & Koo Jeong Kang
  114. Department of Oncology, Gil Medical Center, Gachon University, Incheon, South Korea
    Sung-Min Ahn
  115. Hiroshima University, Hiroshima, Japan
    Hiroshi Aikata, Koji Arihiro, Kazuaki Chayama, Yoshiiku Kawakami & Hideki Ohdan
  116. Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Rehan Akbani, Shaolong Cao, Yiwen Chen, Zechen Chong, Yu Fan, Jun Li, Han Liang, Wenyi Wang, Yumeng Wang & Yuan Yuan
  117. University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Kadir C. Akdemir & Ken Chen
  118. King Faisal Specialist Hospital and Research Centre, Al Maather, Riyadh, Saudi Arabia
    Sultan T. Al-Sedairy
  119. Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
    Fatima Al-Shahrour & Elena Piñeiro-Yáñez
  120. Bioinformatics Core Facility, University Medical Center Hamburg, Hamburg, Germany
    Malik Alawi
  121. Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany
    Malik Alawi & Adam Grundhoff
  122. Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, ON, Canada
    Monique Albert & John Bartlett
  123. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Kenneth Aldape, Russell R. Broaddus, Bogdan Czerniak, Adel El-Naggar, Savitri Krishnamurthy, Alexander J. Lazar & Xiaoping Su
  124. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    Kenneth Aldape
  125. Department of Cellular and Molecular Medicine and Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
    Ludmil B. Alexandrov & Erik N. Bergstrom
  126. UC San Diego Moores Cancer Center, San Diego, CA, USA
    Ludmil B. Alexandrov, Erik N. Bergstrom & Olivier Harismendy
  127. Canada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada
    Adrian Ally, Miruna Balasundaram, Reanne Bowlby, Denise Brooks, Rebecca Carlsen, Eric Chuah, Noreen Dhalla, Robert A. Holt, Steven J. M. Jones, Katayoon Kasaian, Darlene Lee, Haiyan Irene Li, Yussanne Ma, Marco A. Marra, Michael Mayo, Richard A. Moore, Andrew J. Mungall, Karen Mungall, A. Gordon Robertson, Sara Sadeghi, Jacqueline E. Schein, Payal Sipahimalani, Angela Tam, Nina Thiessen & Tina Wong
  128. Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia
    Kathryn Alsop, David D. L. Bowtell, Elizabeth L. Christie, Dariush Etemadmoghadam, Sian Fereday, Dale W. Garsed, Linda Mileshkin, Chris Mitchell, Mark Shackleton, Heather Thorne & Nadia Traficante
  129. Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
    Eva G. Alvarez, Alicia L. Bruzos, Bernardo Rodriguez-Martin, Javier Temes, Jose M. C. Tubio & Jorge Zamora
  130. Department of Zoology, Genetics and Physical Anthropology, (CiMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
    Eva G. Alvarez, Alicia L. Bruzos, Bernardo Rodriguez-Martin, Javier Temes, Jose M. C. Tubio & Jorge Zamora
  131. The Biomedical Research Centre (CINBIO), Universidade de Vigo, Vigo, Spain
    Eva G. Alvarez, Alicia L. Bruzos, Bernardo Rodriguez-Martin, Marta Tojo, Jose M. C. Tubio & Jorge Zamora
  132. Royal National Orthopaedic Hospital - Bolsover, London, UK
    Fernanda Amary
  133. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Samirkumar B. Amin, P. Andrew Futreal & Alexander J. Lazar
  134. Quantitative and Computational Biosciences Graduate Program, Baylor College of Medicine, Houston, TX, USA
    Samirkumar B. Amin, Han Liang & Yumeng Wang
  135. The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA
    Samirkumar B. Amin, Joshy George & Lucas Lochovsky
  136. Genome Informatics Program, Ontario Institute for Cancer Research, Toronto, ON, Canada
    Brice Aminou, Niall J. Byrne, Aurélien Chateigner, Nodirjon Fayzullaev, Vincent Ferretti, George L. Mihaiescu, Hardeep K. Nahal-Bose, Brian D. O’Connor, B. F. Francis Ouellette, Marc D. Perry, Kevin Thai, Qian Xiang, Christina K. Yung & Junjun Zhang
  137. Institute of Human Genetics, Christian-Albrechts-University, Kiel, Germany
    Ole Ammerpohl, Andrea Haake, Cristina López, Julia Richter & Rabea Wagener
  138. Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany
    Ole Ammerpohl, Sietse Aukema, Cristina López, Reiner Siebert & Rabea Wagener
  139. Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, St. Lucia, Brisbane, QLD, Australia
    Matthew J. Anderson, Timothy J. C. Bruxner, Angelika N. Christ, J. Lynn Fink, Ivon Harliwong, Karin S. Kassahn, David K. Miller, Alan J. Robertson & Darrin F. Taylor
  140. Salford Royal NHS Foundation Trust, Salford, UK
    Yeng Ang, Hsiao-Wei Chen, Ritika Kundra & Francisco Sanchez-Vega
  141. Department of Surgery, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy
    Davide Antonello, Claudio Bassi, Narong Khuntikeo, Luca Landoni, Giuseppe Malleo, Giovanni Marchegiani, Neil D. Merrett, Marco Miotto, Salvatore Paiella, Antonio Pea, Paolo Pederzoli, Roberto Salvia, Jaswinder S. Samra, Elisabetta Sereni & Samuel Singer
  142. Molecular and Medical Genetics, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
    Pavana Anur, Myron Peto & Paul T. Spellman
  143. Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada
    Samuel Aparicio
  144. The McDonnell Genome Institute at Washington University, St. Louis, MO, USA
    Elizabeth L. Appelbaum, Matthew H. Bailey, Matthew G. Cordes, Li Ding, Catrina C. Fronick, Lucinda A. Fulton, Robert S. Fulton, Kuan-lin Huang, Reyka Jayasinghe, Elaine R. Mardis, R. Jay Mashl, Michael D. McLellan, Christopher A. Miller, Heather K. Schmidt, Jiayin Wang, Michael C. Wendl, Richard K. Wilson & Tina Wong
  145. University College London, London, UK
    Elizabeth L. Appelbaum, Jonathan D. Kay, Helena Kilpinen, Laurence B. Lovat, Hayley J. Luxton & Hayley C. Whitaker
  146. Division of Cancer Genomics, National Cancer Center Research Institute, National Cancer Center, Tokyo, Japan
    Yasuhito Arai, Natsuko Hama, Fumie Hosoda, Hiromi Nakamura, Tatsuhiro Shibata, Yasushi Totoki & Shinichi Yachida
  147. DLR Project Management Agency, Bonn, Germany
    Axel Aretz
  148. Tokyo Women’s Medical University, Tokyo, Japan
    Shun-ichi Ariizumi & Masakazu Yamamoto
  149. Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Joshua Armenia, Hsiao-Wei Chen, Jianjiong Gao, Ritika Kundra, Francisco Sanchez-Vega, Nikolaus Schultz & Hongxin Zhang
  150. Los Alamos National Laboratory, Los Alamos, NM, USA
    Laurent Arnould
  151. Department of Pathology, University Health Network, Toronto General Hospital, Toronto, ON, Canada
    Sylvia Asa, Michael H. A. Roehrl & Theodorus Van der Kwast
  152. Nottingham University Hospitals NHS Trust, Nottingham, UK
    Sylvia Asa, Simon L. Parsons & Ming Tsao
  153. Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Yassen Assenov
  154. Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada
    Gurnit Atwal, Philip Awadalla, Jonathan Barenboim, Vinayak Bhandari, Ivan Borozan, Paul C. Boutros, Lewis Jonathan Dursi, Shadrielle M. G. Espiritu, Natalie S. Fox, Michael Fraser, Syed Haider, Vincent Huang, Keren Isaev, Wei Jiao, Christopher M. Lalansingh, Emilie Lalonde, Fabien C. Lamaze, Constance H. Li, Julie Livingstone, Christine P’ng, Marta Paczkowska, Stephenie D. Prokopec, Jüri Reimand, Veronica Y. Sabelnykova, Adriana Salcedo, Yu-Jia Shiah, Solomon I. Shorser, Shimin Shuai, Jared T. Simpson, Lincoln D. Stein, Ren X. Sun, Lina Wadi, Gavin W. Wilson, Adam J. Wright, Takafumi N. Yamaguchi, Fouad Yousif & Denis Yuen
  155. Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
    Gurnit Atwal, Philip Awadalla, Gary D. Bader, Shimin Shuai & Lincoln D. Stein
  156. Vector Institute, Toronto, ON, Canada
    Gurnit Atwal, Quaid D. Morris, Yulia Rubanova & Jeffrey A. Wintersinger
  157. Hematopathology Section, Institute of Pathology, Christian-Albrechts-University, Kiel, Germany
    Sietse Aukema, Wolfram Klapper, Julia Richter & Monika Szczepanowski
  158. Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J. Todd Auman & Charles M. Perou
  159. Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway
    Miriam R. R. Aure, Anne-Lise Børresen-Dale & Anita Langerød
  160. Pathology, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
    Marta Aymerich
  161. Department of Veterinary Medicine, Transmissible Cancer Group, University of Cambridge, Cambridge, UK
    Adrian Baez-Ortega
  162. Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA
    Matthew H. Bailey, Li Ding, Robert S. Fulton, Ramaswamy Govindan & Michael D. McLellan
  163. Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
    Peter J. Bailey, Andrew V. Biankin, David K. Chang, Susanna L. Cooke, Fraser R. Duthie, Janet S. Graham, Nigel B. Jamieson, Elizabeth A. Musgrove & Derek W. Wright
  164. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Saianand Balu, Tom Bodenheimer, D. Neil Hayes, Austin J. Hepperla, Katherine A. Hoadley, Alan P. Hoyle, Stuart R. Jefferys, Shaowu Meng, Lisle E. Mose, Grant Sanders, Yan Shi, Janae V. Simons & Matthew G. Soloway
  165. Broad Institute of MIT and Harvard, Cambridge, MA, USA
    Pratiti Bandopadhayay, Rameen Beroukhim, Angela N. Brooks, Susan Bullman, John Busanovich, Andrew D. Cherniack, Juok Cho, Carrie Cibulskis, Kristian Cibulskis, David Craft, Timothy Defreitas, Andrew J. Dunford, Scott Frazer, Stacey B. Gabriel, Nils Gehlenborg, Gad Getz, Manaswi Gupta, Gavin Ha, Nicholas J. Haradhvala, David I. Heiman, Julian M. Hess, Manolis Kellis, Jaegil Kim, Kiran Kumar, Kirsten Kübler, Eric Lander, Michael S. Lawrence, Ignaty Leshchiner, Pei Lin, Ziao Lin, Dimitri Livitz, Yosef E. Maruvka, Samuel R. Meier, Matthew Meyerson, Michael S. Noble, Chandra Sekhar Pedamallu, Paz Polak, Esther Rheinbay, Daniel Rosebrock, Mara Rosenberg, Gordon Saksena, Richard Sallari, Steven E. Schumacher, Ayellet V. Segre, Ofer Shapira, Juliann Shih, Nasa Sinnott-Armstrong, Oliver Spiro, Chip Stewart, Amaro Taylor-Weiner, Grace Tiao, Douglas Voet, Jeremiah A. Wala, Cheng-Zhong Zhang & Hailei Zhang
  166. Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA, USA
    Pratiti Bandopadhayay
  167. Department of Pediatrics, Harvard Medical School, Boston, MA, USA
    Pratiti Bandopadhayay
  168. Leeds Institute of Medical Research @ St. James’s, University of Leeds, St. James’s University Hospital, Leeds, UK
    Rosamonde E. Banks & Naveen Vasudev
  169. Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy
    Stefano Barbi, Vincenzo Corbo & Michele Simbolo
  170. Department of Surgery, Princess Alexandra Hospital, Brisbane, QLD, Australia
    Andrew P. Barbour
  171. Surgical Oncology Group, Diamantina Institute, University of Queensland, Brisbane, QLD, Australia
    Andrew P. Barbour
  172. Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA
    Jill Barnholtz-Sloan
  173. Research Health Analytics and Informatics, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
    Jill Barnholtz-Sloan
  174. Gloucester Royal Hospital, Gloucester, UK
    Hugh Barr
  175. European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK
    Elisabet Barrera, Wojciech Bazant, Ewan Birney, Rich Boyce, Alvis Brazma, Andy Cafferkey, Claudia Calabrese, Paul Flicek, Nuno A. Fonseca, Anja Füllgrabe, Moritz Gerstung, Santiago Gonzalez, Liliana Greger, Maria Keays, Jan O. Korbel, Alfonso Muñoz, Steven J. Newhouse, David Ocana, Irene Papatheodorou, Robert Petryszak, Roland F. Schwarz, Charles Short, Oliver Stegle & Lara Urban
  176. Diagnostic Development, Ontario Institute for Cancer Research, Toronto, ON, Canada
    John Bartlett & Ilinca Lungu
  177. Barcelona Supercomputing Center (BSC), Barcelona, Spain
    Javier Bartolome, Mattia Bosio, Ana Dueso-Barroso, J. Lynn Fink, Josep L. L. Gelpi, Ana Milovanovic, Montserrat Puiggròs, Javier Bartolomé Rodriguez, Romina Royo, David Torrents, Alfonso Valencia, Miguel Vazquez, David Vicente & Izar Villasante
  178. Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
    Oliver F. Bathe
  179. Departments of Surgery and Oncology, University of Calgary, Calgary, AB, Canada
    Oliver F. Bathe
  180. Department of Pathology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway
    Daniel Baumhoer & Bodil Bjerkehagen
  181. PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON, Canada
    Prashant Bavi, Michelle Chan-Seng-Yue, Sean Cleary, Robert E. Denroche, Steven Gallinger, Robert C. Grant, Gun Ho Jang, Sangeetha Kalimuthu, Ilinca Lungu, John D. McPherson, Faiyaz Notta, Michael H. A. Roehrl, Gavin W. Wilson & Julie M. Wilson
  182. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Stephen B. Baylin, Nilanjan Chatterjee, Leslie Cope, Ludmila Danilova & Ralph H. Hruban
  183. University Hospital Southampton NHS Foundation Trust, Southampton, UK
    Stephen B. Baylin & Tim Dudderidge
  184. Royal Stoke University Hospital, Stoke-on-Trent, UK
    Duncan Beardsmore & Christopher Umbricht
  185. Genome Sequence Informatics, Ontario Institute for Cancer Research, Toronto, ON, Canada
    Timothy A. Beck, Bob Gibson, Lawrence E. Heisler, Xuemei Luo & Morgan L. Taschuk
  186. Human Longevity Inc, San Diego, CA, USA
    Timothy A. Beck
  187. Olivia Newton-John Cancer Research Institute, La Trobe University, Heidelberg, VIC, Australia
    Andreas Behren & Jonathan Cebon
  188. Computer Network Information Center, Chinese Academy of Sciences, Beijing, China
    Beifang Niu
  189. Genome Canada, Ottawa, ON, Canada
    Cindy Bell
  190. CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
    Sergi Beltran, Ivo G. Gut, Marta Gut, Simon C. Heath, Tomas Marques-Bonet, Arcadi Navarro, Miranda D. Stobbe, Jean-Rémi Trotta & Justin P. Whalley
  191. Universitat Pompeu Fabra (UPF), Barcelona, Spain
    Sergi Beltran, Mattia Bosio, German M. Demidov, Oliver Drechsel, Ivo G. Gut, Marta Gut, Simon C. Heath, Francesc Muyas, Stephan Ossowski, Aparna Prasad, Raquel Rabionet, Miranda D. Stobbe & Hana Susak
  192. Buck Institute for Research on Aging, Novato, CA, USA
    Christopher Benz & Christina Yau
  193. Duke University Medical Center, Durham, NC, USA
    Andrew Berchuck
  194. Department of Human Genetics, Hannover Medical School, Hannover, Germany
    Anke K. Bergmann
  195. Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    Benjamin P. Berman & Huy Q. Dinh
  196. Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    Benjamin P. Berman
  197. The Hebrew University Faculty of Medicine, Jerusalem, Israel
    Benjamin P. Berman
  198. Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
    Daniel M. Berney & Yong-Jie Lu
  199. Department of Computer Science, Bioinformatics Group, University of Leipzig, Leipzig, Germany
    Stephan H. Bernhart, Hans Binder, Steve Hoffmann & Peter F. Stadler
  200. Interdisciplinary Center for Bioinformatics, University of Leipzig, Leipzig, Germany
    Stephan H. Bernhart, Hans Binder, Steve Hoffmann, Helene Kretzmer & Peter F. Stadler
  201. Transcriptome Bioinformatics, LIFE Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany
    Stephan H. Bernhart, Steve Hoffmann, Helene Kretzmer & Peter F. Stadler
  202. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
    Rameen Beroukhim, Angela N. Brooks, Susan Bullman, Andrew D. Cherniack, Levi Garraway, Matthew Meyerson, Chandra Sekhar Pedamallu, Steven E. Schumacher, Juliann Shih & Jeremiah A. Wala
  203. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA
    Rameen Beroukhim, Aquila Fatima, Andrea L. Richardson, Steven E. Schumacher, Ofer Shapira, Andrew Tutt & Jeremiah A. Wala
  204. Harvard Medical School, Boston, MA, USA
    Rameen Beroukhim, Gad Getz, Kirsten Kübler, Matthew Meyerson, Chandra Sekhar Pedamallu, Paz Polak, Esther Rheinbay & Jeremiah A. Wala
  205. USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA
    Mario Berrios, Moiz S. Bootwalla, Andrea Holbrook, Phillip H. Lai, Dennis T. Maglinte, David J. Van Den Berg & Daniel J. Weisenberger
  206. Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy
    Samantha Bersani, Ivana Cataldo, Claudio Luchini & Maria Scardoni
  207. Department of Mathematics, Aarhus University, Aarhus, Denmark
    Johanna Bertl & Asger Hobolth
  208. Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus N, Denmark
    Johanna Bertl, Henrik Hornshøj, Malene Juul, Randi Istrup Juul, Tobias Madsen, Morten Muhlig Nielsen & Jakob Skou Pedersen
  209. Instituto Carlos Slim de la Salud, Mexico City, Mexico
    Miguel Betancourt
  210. Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
    Vinayak Bhandari, Paul C. Boutros, Robert G. Bristow, Keren Isaev, Constance H. Li, Jüri Reimand, Michael H. A. Roehrl & Bradly G. Wouters
  211. Cancer Division, Garvan Institute of Medical Research, Kinghorn Cancer Centre, University of New South Wales (UNSW Sydney), Sydney, NSW, Australia
    Andrew V. Biankin, David K. Chang, Lorraine A. Chantrill, Angela Chou, Anthony J. Gill, Amber L. Johns, James G. Kench, David K. Miller, Adnan M. Nagrial, Marina Pajic, Mark Pinese, Ilse Rooman, Christopher J. Scarlett, Christopher W. Toon & Jianmin Wu
  212. South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales (UNSW Sydney), Liverpool, NSW, Australia
    Andrew V. Biankin
  213. West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK
    Andrew V. Biankin & Nigel B. Jamieson
  214. Center for Digital Health, Berlin Institute of Health and Charitè - Universitätsmedizin Berlin, Berlin, Germany
    Matthias Bieg
  215. Heidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg, Germany
    Matthias Bieg, Ivo Buchhalter, Barbara Hutter & Nagarajan Paramasivam
  216. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA
    Darell Bigner
  217. Massachusetts General Hospital, Boston, MA, USA
    Michael Birrer, Vikram Deshpande, William C. Faquin, Nicholas J. Haradhvala, Kirsten Kübler, Michael S. Lawrence, David N. Louis, Yosef E. Maruvka, G. Petur Nielsen, Esther Rheinbay, Mara Rosenberg, Dennis C. Sgroi & Chin-Lee Wu
  218. National Institute of Biomedical Genomics, Kalyani, West Bengal, India
    Nidhan K. Biswas, Arindam Maitra & Partha P. Majumder
  219. Institute of Clinical Medicine and Institute of Oral Biology, University of Oslo, Oslo, Norway
    Bodil Bjerkehagen
  220. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Lori Boice, Mei Huang, Sonia Puig & Leigh B. Thorne
  221. ARC-Net Centre for Applied Research on Cancer, University and Hospital Trust of Verona, Verona, Italy
    Giada Bonizzato, Cinzia Cantù, Ivana Cataldo, Vincenzo Corbo, Sonia Grimaldi, Rita T. Lawlor, Andrea Mafficini, Borislav C. Rusev, Aldo Scarpa, Katarzyna O. Sikora, Nicola Sperandio, Alain Viari & Caterina Vicentini
  222. The Institute of Cancer Research, London, UK
    Johann S. De Bono, Niedzica Camacho, Colin S. Cooper, Sandra E. Edwards, Rosalind A. Eeles, Zsofia Kote-Jarai, Daniel A. Leongamornlert, Lucy Matthews & Sue Merson
  223. Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore
    Arnoud Boot, Ioana Cutcutache, Mi Ni Huang, John R. McPherson, Steven G. Rozen & Yang Wu
  224. Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore
    Arnoud Boot, Ioana Cutcutache, Mi Ni Huang, John R. McPherson, Steven G. Rozen, Patrick Tan, Bin Tean Teh & Yang Wu
  225. Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden
    Ake Borg, Markus Ringnér & Johan Staaf
  226. Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany
    Arndt Borkhardt & Jessica I. Hoell
  227. Laboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
    Keith A. Boroevich, Todd A. Johnson, Michael S. Lawrence & Tatsuhiko Tsunoda
  228. RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
    Keith A. Boroevich, Akihiro Fujimoto, Masashi Fujita, Mayuko Furuta, Kazuhiro Maejima, Hidewaki Nakagawa, Kaoru Nakano & Aya Sasaki-Oku
  229. Department of Internal Medicine/Hematology, Friedrich-Ebert-Hospital, Neumünster, Germany
    Christoph Borst & Siegfried Haas
  230. Departments of Dermatology and Pathology, Yale University, New Haven, CT, USA
    Marcus Bosenberg
  231. Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain
    Mattia Bosio, German M. Demidov, Oliver Drechsel, Georgia Escaramis, Xavier Estivill, Aliaksei Z. Holik, Francesc Muyas, Stephan Ossowski, Raquel Rabionet & Hana Susak
  232. Radcliffe Department of Medicine, University of Oxford, Oxford, UK
    Jacqueline Boultwood
  233. Canadian Center for Computational Genomics, McGill University, Montreal, QC, Canada
    Guillaume Bourque
  234. Department of Human Genetics, McGill University, Montreal, QC, Canada
    Guillaume Bourque, Mark Lathrop & Yasser Riazalhosseini
  235. Department of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA
    Paul C. Boutros
  236. Department of Pharmacology, University of Toronto, Toronto, ON, Canada
    Paul C. Boutros
  237. Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland
    G. Steven Bova & Tapio Visakorpi
  238. Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
    David T. Bowen
  239. Translational Research and Innovation, Centre Léon Bérard, Lyon, France
    Sandrine Boyault
  240. Fox Chase Cancer Center, Philadelphia, PA, USA
    Jeffrey Boyd & Elaine R. Mardis
  241. International Agency for Research on Cancer, World Health Organization, Lyon, France
    Paul Brennan & Ghislaine Scelo
  242. Earlham Institute, Norwich, UK
    Daniel S. Brewer & Colin S. Cooper
  243. Norwich Medical School, University of East Anglia, Norwich, UK
    Daniel S. Brewer & Colin S. Cooper
  244. Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, HB, The Netherlands
    Arie B. Brinkman
  245. CRUK Manchester Institute and Centre, Manchester, UK
    Robert G. Bristow
  246. Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada
    Robert G. Bristow
  247. Division of Cancer Sciences, Manchester Cancer Research Centre, University of Manchester, Manchester, UK
    Robert G. Bristow
  248. Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
    Robert G. Bristow & Fei-Fei Fei Liu
  249. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
    Jane E. Brock & Sabina Signoretti
  250. Department of Surgery, Division of Thoracic Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Malcolm Brock
  251. Division of Molecular Pathology, The Netherlands Cancer Institute, Oncode Institute, Amsterdam, CX, The Netherlands
    Annegien Broeks & Jos Jonkers
  252. Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, CA, USA
    Angela N. Brooks, David Haan, Maximillian G. Marin, Thomas J. Matthew, Yulia Newton, Cameron M. Soulette & Joshua M. Stuart
  253. UC Santa Cruz Genomics Institute, University of California Santa Cruz, Santa Cruz, CA, USA
    Angela N. Brooks, Brian Craft, Mary J. Goldman, David Haussler, Joshua M. Stuart & Jingchun Zhu
  254. Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Benedikt Brors, Lars Feuerbach, Chen Hong, Charles David Imbusch & Lina Sieverling
  255. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
    Benedikt Brors, Barbara Hutter, Peter Lichter, Dirk Schadendorf & Holger Sültmann
  256. National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany
    Benedikt Brors, Barbara Hutter, Holger Sültmann & Thorsten Zenz
  257. Center for Biological Sequence Analysis, Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark
    Søren Brunak
  258. Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark
    Søren Brunak
  259. Institute for Molecular Bioscience, University of Queensland, St. Lucia, Brisbane, QLD, Australia
    Timothy J. C. Bruxner, Oliver Holmes, Stephen H. Kazakoff, Conrad R. Leonard, Felicity Newell, Katia Nones, Ann-Marie Patch, John V. Pearson, Michael C. Quinn, Nick M. Waddell, Nicola Waddell, Scott Wood & Qinying Xu
  260. Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA
    Alex Buchanan & Kyle Ellrott
  261. Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Ivo Buchhalter, Calvin Wing Yiu Chan, Roland Eils, Michael C. Heinold, Carl Herrmann, Natalie Jäger, Rolf Kabbe, Jules N. A. Kerssemakers, Kortine Kleinheinz, Nagarajan Paramasivam, Manuel Prinz, Matthias Schlesner & Johannes Werner
  262. Institute of Pharmacy and Molecular Biotechnology and BioQuant, Heidelberg University, Heidelberg, Germany
    Ivo Buchhalter, Roland Eils, Michael C. Heinold, Carl Herrmann, Daniel Hübschmann, Kortine Kleinheinz & Umut H. Toprak
  263. Federal Ministry of Education and Research, Berlin, Germany
    Christiane Buchholz
  264. Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia
    Hazel Burke, Ricardo De Paoli-Iseppi, Nicholas K. Hayward, Peter Hersey, Valerie Jakrot, Hojabr Kakavand, Georgina V. Long, Graham J. Mann, Robyn P. M. Saw, Richard A. Scolyer, Ping Shang, Andrew J. Spillane, Jonathan R. Stretch, John F. F. Thompson & James S. Wilmott
  265. Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany
    Birgit Burkhardt
  266. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Kathleen H. Burns & Christopher Umbricht
  267. McKusick-Nathans Institute of Genetic Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Kathleen H. Burns
  268. Foundation Medicine, Inc, Cambridge, MA, USA
    John Busanovich
  269. Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA
    Carlos D. Bustamante & Francisco M. De La Vega
  270. Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
    Carlos D. Bustamante, Francisco M. De La Vega, Suyash S. Shringarpure, Nasa Sinnott-Armstrong & Mark H. Wright
  271. Bakar Computational Health Sciences Institute and Department of Pediatrics, University of California, San Francisco, CA, USA
    Atul J. Butte & Jieming Chen
  272. Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
    Anne-Lise Børresen-Dale
  273. National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Samantha J. Caesar-Johnson, John A. Demchok, Ina Felau, Roy Tarnuzzer, Zhining Wang, Liming Yang, Jean C. Zenklusen & Jiashan Zhang
  274. Royal Marsden NHS Foundation Trust, London and Sutton, UK
    Declan Cahill, Nening M. Dennis, Tim Dudderidge, Rosalind A. Eeles, Cyril Fisher, Steven Hazell, Vincent Khoo, Pardeep Kumar, Naomi Livni, Erik Mayer, David Nicol, Christopher Ogden, Edward W. Rowe, Sarah Thomas, Alan Thompson & Nicholas van As
  275. Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
    Claudia Calabrese, Serap Erkek, Moritz Gerstung, Santiago Gonzalez, Nina Habermann, Wolfgang Huber, Lara Jerman, Jan O. Korbel, Esa Pitkänen, Benjamin Raeder, Tobias Rausch, Vasilisa A. Rudneva, Oliver Stegle, Stephanie Sungalee, Lara Urban, Sebastian M. Waszak, Joachim Weischenfeldt & Sergei Yakneen
  276. Department of Oncology, University of Cambridge, Cambridge, UK
    Carlos Caldas & Suet-Feung Chin
  277. Li Ka Shing Centre, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
    Carlos Caldas, Suet-Feung Chin, Ruben M. Drews, Paul A. Edwards, Matthew Eldridge, Steve Hawkins, Andy G. Lynch, Geoff Macintyre, Florian Markowetz, Charlie E. Massie, David E. Neal, Simon Tavaré & Ke Yuan
  278. Institut Gustave Roussy, Villejuif, France
    Fabien Calvo
  279. Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
    Peter J. Campbell, Vincent J. Gnanapragasam, William Howat, Thomas J. Mitchell, David E. Neal, Nimish C. Shah & Anne Y. Warren
  280. Department of Haematology, University of Cambridge, Cambridge, UK
    Peter J. Campbell
  281. Anatomia Patológica, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
    Elias Campo
  282. Spanish Ministry of Science and Innovation, Madrid, Spain
    Elias Campo
  283. University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
    Thomas E. Carey
  284. Department for BioMedical Research, University of Bern, Bern, Switzerland
    Joana Carlevaro-Fita
  285. Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland
    Joana Carlevaro-Fita, Rory Johnson & Andrés Lanzós
  286. Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland
    Joana Carlevaro-Fita & Andrés Lanzós
  287. University of Pavia, Pavia, Italy
    Mario Cazzola & Luca Malcovati
  288. University of Alabama at Birmingham, Birmingham, AL, USA
    Robert Cerfolio
  289. UHN Program in BioSpecimen Sciences, Toronto General Hospital, Toronto, ON, Canada
    Dianne E. Chadwick, Sheng-Ben Liang, Michael H. A. Roehrl & Sagedeh Shahabi
  290. Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    Dimple Chakravarty
  291. Centre for Law and Genetics, University of Tasmania, Sandy Bay Campus, Hobart, TAS, Australia
    Don Chalmers
  292. Faculty of Biosciences, Heidelberg University, Heidelberg, Germany
    Calvin Wing Yiu Chan, Chen Hong & Lina Sieverling
  293. Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
    Kin Chan
  294. Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA
    Vishal S. Chandan
  295. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Stephen J. Chanock, Xing Hua, Lisa Mirabello, Lei Song & Bin Zhu
  296. Illawarra Shoalhaven Local Health District L3 Illawarra Cancer Care Centre, Wollongong Hospital, Wollongong, NSW, Australia
    Lorraine A. Chantrill
  297. BioForA, French National Institute for Agriculture, Food, and Environment (INRAE), ONF, Orléans, France
    Aurélien Chateigner
  298. Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
    Nilanjan Chatterjee
  299. University of California San Diego, San Diego, CA, USA
    Zhaohong Chen, Michelle T. Dow, Claudiu Farcas, S. M. Ashiqul Islam, Antonios Koures, Lucila Ohno-Machado, Christos Sotiriou & Ashley Williams
  300. Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA
    Jeremy Chien
  301. Centre for Cancer Research, The Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia
    Yoke-Eng Chiew, Angela Chou, Jillian A. Hung, Catherine J. Kennedy, Graham J. Mann, Gulietta M. Pupo, Sarah-Jane Schramm, Varsha Tembe & Anna deFazio
  302. Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia
    Yoke-Eng Chiew, Jillian A. Hung, Catherine J. Kennedy & Anna deFazio
  303. PDXen Biosystems Inc, Seoul, South Korea
    Sunghoon Cho
  304. Korea Advanced Institute of Science and Technology, Daejeon, South Korea
    Jung Kyoon Choi, Young Seok Ju & Christopher J. Yoon
  305. Electronics and Telecommunications Research Institute, Daejeon, South Korea
    Wan Choi, Seung-Hyup Jeon, Hyunghwan Kim & Youngchoon Woo
  306. Institut National du Cancer (INCA), Boulogne-Billancourt, France
    Christine Chomienne & Iris Pauporté
  307. Department of Genetics, Informatics Institute, University of Alabama at Birmingham, Birmingham, AL, USA
    Zechen Chong
  308. Division of Medical Oncology, National Cancer Centre, Singapore, Singapore
    Su Pin Choo
  309. Medical Oncology, University and Hospital Trust of Verona, Verona, Italy
    Sara Cingarlini & Michele Milella
  310. Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany
    Alexander Claviez
  311. Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, ON, Canada
    Sean Cleary, Ashton A. Connor & Steven Gallinger
  312. School of Biological Sciences, University of Auckland, Auckland, New Zealand
    Nicole Cloonan
  313. Department of Surgery, University of Melbourne, Parkville, VIC, Australia
    Marek Cmero
  314. The Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, VIC, Australia
    Marek Cmero
  315. Walter and Eliza Hall Institute, Parkville, VIC, Australia
    Marek Cmero
  316. Vancouver Prostate Centre, Vancouver, Canada
    Colin C. Collins, Nilgun Donmez, Faraz Hach, Salem Malikic, S. Cenk Sahinalp, Iman Sarrafi & Raunak Shrestha
  317. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
    Ashton A. Connor, Steven Gallinger, Robert C. Grant, Treasa A. McPherson & Iris Selander
  318. University of East Anglia, Norwich, UK
    Colin S. Cooper
  319. Norfolk and Norwich University Hospital NHS Trust, Norwich, UK
    Matthew G. Cordes, Catrina C. Fronick & Tom Roques
  320. Victorian Institute of Forensic Medicine, Southbank, VIC, Australia
    Stephen M. Cordner
  321. Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA
    Isidro Cortés-Ciriano, Jake June-Koo Lee & Peter J. Park
  322. Department of Chemistry, Centre for Molecular Science Informatics, University of Cambridge, Cambridge, UK
    Isidro Cortés-Ciriano
  323. Ludwig Center at Harvard Medical School, Boston, MA, USA
    Isidro Cortés-Ciriano, Jake June-Koo Lee & Peter J. Park
  324. Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
    Kyle Covington, HarshaVardhan Doddapaneni, Richard A. Gibbs, Jianhong Hu, Joy C. Jayaseelan, Viktoriya Korchina, Lora Lewis, Donna M. Muzny, Linghua Wang, David A. Wheeler & Liu Xi
  325. Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia
    Prue A. Cowin, Anne Hamilton, Gisela Mir Arnau & Ravikiran Vedururu
  326. Physics Division, Optimization and Systems Biology Lab, Massachusetts General Hospital, Boston, MA, USA
    David Craft
  327. Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    Chad J. Creighton
  328. University of Cologne, Cologne, Germany
    Yupeng Cun, Martin Peifer & Tsun-Po Yang
  329. International Genomics Consortium, Phoenix, AZ, USA
    Erin Curley & Troy Shelton
  330. Genomics Research Program, Ontario Institute for Cancer Research, Toronto, ON, Canada
    Karolina Czajka, Jenna Eagles, Thomas J. Hudson, Jeremy Johns, Faridah Mbabaali, John D. McPherson, Jessica K. Miller, Danielle Pasternack, Michelle Sam & Lee E. Timms
  331. Barking Havering and Redbridge University Hospitals NHS Trust, Romford, UK
    Bogdan Czerniak, Adel El-Naggar & David Khoo
  332. Children’s Hospital at Westmead, University of Sydney, Sydney, NSW, Australia
    Rebecca A. Dagg
  333. Department of Medicine, Section of Endocrinology, University and Hospital Trust of Verona, Verona, Italy
    Maria Vittoria Davi
  334. Computational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Natalie R. Davidson, Andre Kahles, Kjong-Van Lehmann, Alessandro Pastore, Gunnar Rätsch, Chris Sander, Yasin Senbabaoglu & Nicholas D. Socci
  335. Department of Biology, ETH Zurich, Zürich, Switzerland
    Natalie R. Davidson, Andre Kahles, Kjong-Van Lehmann, Gunnar Rätsch & Stefan G. Stark
  336. Department of Computer Science, ETH Zurich, Zurich, Switzerland
    Natalie R. Davidson, Andre Kahles, Kjong-Van Lehmann & Gunnar Rätsch
  337. SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
    Natalie R. Davidson, Andre Kahles, Kjong-Van Lehmann, Gunnar Rätsch & Stefan G. Stark
  338. Weill Cornell Medical College, New York, NY, USA
    Natalie R. Davidson, Bishoy M. Faltas & Gunnar Rätsch
  339. Academic Department of Medical Genetics, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
    Helen Davies & Serena Nik-Zainal
  340. MRC Cancer Unit, University of Cambridge, Cambridge, UK
    Helen Davies, Rebecca C. Fitzgerald, Nicola Grehan, Serena Nik-Zainal & Maria O’Donovan
  341. Departments of Pediatrics and Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Ian J. Davis
  342. Seven Bridges Genomics, Charlestown, MA, USA
    Brandi N. Davis-Dusenbery, Sinisa Ivkovic, Milena Kovacevic, Ana Mijalkovic Lazic, Sanja Mijalkovic, Mia Nastic, Petar Radovic & Nebojsa Tijanic
  343. Annai Systems, Inc, Carlsbad, CA, USA
    Francisco M. De La Vega, Tal Shmaya & Dai-Ying Wu
  344. Department of Pathology, General Hospital of Treviso, Department of Medicine, University of Padua, Treviso, Italy
    Angelo P. Dei Tos
  345. Department of Computational Biology, University of Lausanne, Lausanne, Switzerland
    Olivier Delaneau
  346. Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, CH, Switzerland
    Olivier Delaneau
  347. Swiss Institute of Bioinformatics, University of Geneva, Geneva, CH, Switzerland
    Olivier Delaneau
  348. The Francis Crick Institute, London, UK
    Jonas Demeulemeester, Stefan C. Dentro, Matthew W. Fittall, Kerstin Haase, Clemency Jolly, Maxime Tarabichi & Peter Van Loo
  349. University of Leuven, Leuven, Belgium
    Jonas Demeulemeester & Peter Van Loo
  350. Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany
    German M. Demidov, Francesc Muyas & Stephan Ossowski
  351. Computational and Systems Biology, Genome Institute of Singapore, Singapore, Singapore
    Deniz Demircioğlu & Jonathan Göke
  352. School of Computing, National University of Singapore, Singapore, Singapore
    Deniz Demircioğlu
  353. Big Data Institute, Li Ka Shing Centre, University of Oxford, Oxford, UK
    Stefan C. Dentro & David C. Wedge
  354. Biomedical Data Science Laboratory, Francis Crick Institute, London, UK
    Nikita Desai
  355. Bioinformatics Group, Department of Computer Science, University College London, London, UK
    Nikita Desai
  356. The Edward S. Rogers Sr. Department of Electrical and Computer Engineering, University of Toronto, Toronto, ON, Canada
    Amit G. Deshwar
  357. Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Brussels, Belgium
    Christine Desmedt
  358. Department of Oncology, Laboratory for Translational Breast Cancer Research, KU Leuven, Leuven, Belgium
    Christine Desmedt
  359. Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain
    Jordi Deu-Pons, Joan Frigola, Abel Gonzalez-Perez, Ferran Muiños, Loris Mularoni, Oriol Pich, Iker Reyes-Salazar, Carlota Rubio-Perez, Radhakrishnan Sabarinathan & David Tamborero
  360. Research Program on Biomedical Informatics, Universitat Pompeu Fabra, Barcelona, Spain
    Jordi Deu-Pons, Abel Gonzalez-Perez, Ferran Muiños, Loris Mularoni, Oriol Pich, Carlota Rubio-Perez, Radhakrishnan Sabarinathan & David Tamborero
  361. Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada
    Neesha C. Dhani, David Hedley & Malcolm J. Moore
  362. Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA
    Priyanka Dhingra, Ekta Khurana, Eric Minwei Liu & Alexander Martinez-Fundichely
  363. Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA
    Priyanka Dhingra, Ekta Khurana, Eric Minwei Liu & Alexander Martinez-Fundichely
  364. Department of Pathology, UPMC Shadyside, Pittsburgh, PA, USA
    Rajiv Dhir
  365. Independent Consultant, Wellesley, USA
    Anthony DiBiase
  366. Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
    Klev Diamanti, Jan Komorowski & Husen M. Umer
  367. Department of Medicine and Department of Genetics, Washington University School of Medicine, St. Louis, St. Louis, MO, USA
    Li Ding, Robert S. Fulton, Michael D. McLellan, Michael C. Wendl & Venkata D. Yellapantula
  368. Hefei University of Technology, Anhui, China
    Shuai Ding & Shanlin Yang
  369. Translational Cancer Research Unit, GZA Hospitals St.-Augustinus, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
    Luc Dirix, Steven Van Laere, Gert G. Van den Eynden & Peter Vermeulen
  370. Simon Fraser University, Burnaby, BC, Canada
    Nilgun Donmez, Ermin Hodzic, Salem Malikic, S. Cenk Sahinalp & Iman Sarrafi
  371. University of Pennsylvania, Philadelphia, PA, USA
    Ronny Drapkin
  372. Faculty of Science and Technology, University of Vic—Central University of Catalonia (UVic-UCC), Vic, Spain
    Ana Dueso-Barroso
  373. The Wellcome Trust, London, UK
    Michael Dunn
  374. The Hospital for Sick Children, Toronto, ON, Canada
    Lewis Jonathan Dursi
  375. Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK
    Fraser R. Duthie
  376. Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
    Ken Dutton-Regester, Nicholas K. Hayward, Oliver Holmes, Peter A. Johansson, Stephen H. Kazakoff, Conrad R. Leonard, Felicity Newell, Katia Nones, Ann-Marie Patch, John V. Pearson, Antonia L. Pritchard, Michael C. Quinn, Paresh Vyas, Nicola Waddell, Scott Wood & Qinying Xu
  377. Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
    Douglas F. Easton
  378. Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK
    Douglas F. Easton
  379. Prostate Cancer Canada, Toronto, ON, Canada
    Stuart Edmonds
  380. University of Cambridge, Cambridge, UK
    Paul A. Edwards, Anthony R. Green, Andy G. Lynch, Florian Markowetz & Thomas J. Mitchell
  381. Department of Laboratory Medicine, Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund University, Lund, Sweden
    Anna Ehinger
  382. Heidelberg University, Heidelberg, Germany
    Juergen Eils, Roland Eils & Daniel Hübschmann
  383. New BIH Digital Health Center, Berlin Institute of Health (BIH) and Charité - Universitätsmedizin Berlin, Berlin, Germany
    Juergen Eils, Roland Eils & Chris Lawerenz
  384. CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
    Georgia Escaramis
  385. Research Group on Statistics, Econometrics and Health (GRECS), UdG, Barcelona, Spain
    Georgia Escaramis
  386. Quantitative Genomics Laboratories (qGenomics), Barcelona, Spain
    Xavier Estivill
  387. Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland
    Jorunn E. Eyfjord, Holmfridur Hilmarsdottir & Jon G. Jonasson
  388. State Key Laboratory of Cancer Biology, and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Shaanxi, China
    Daiming Fan & Yongzhan Nie
  389. Department of Medicine (DIMED), Surgical Pathology Unit, University of Padua, Padua, Italy
    Matteo Fassan
  390. Rigshospitalet, Copenhagen, Denmark
    Francesco Favero
  391. Center for Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Martin L. Ferguson
  392. Department of Biochemistry and Molecular Medicine, University of Montreal, Montreal, QC, Canada
    Vincent Ferretti
  393. Australian Institute of Tropical Health and Medicine, James Cook University, Douglas, QLD, Australia
    Matthew A. Field
  394. Department of Neuro-Oncology, Istituto Neurologico Besta, Milano, Italy
    Gaetano Finocchiaro
  395. Bioplatforms Australia, North Ryde, NSW, Australia
    Anna Fitzgerald & Catherine A. Shang
  396. Department of Pathology (Research), University College London Cancer Institute, London, UK
    Adrienne M. Flanagan
  397. Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada
    Neil E. Fleshner
  398. Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Centre, Erasmus Medical Center, Rotterdam, CN, The Netherlands
    John A. Foekens, John W. M. Martens, F. Germán Rodríguez-González, Anieta M. Sieuwerts & Marcel Smid
  399. The University of Queensland Thoracic Research Centre, The Prince Charles Hospital, Brisbane, QLD, Australia
    Kwun M. Fong
  400. CIBIO/InBIO - Research Center in Biodiversity and Genetic Resources, Universidade do Porto, Vairão, Portugal
    Nuno A. Fonseca
  401. HCA Laboratories, London, UK
    Christopher S. Foster
  402. University of Liverpool, Liverpool, UK
    Christopher S. Foster
  403. The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
    Milana Frenkel-Morgenstern
  404. Department of Neurosurgery, University of Florida, Gainesville, FL, USA
    William Friedman
  405. Department of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    Masashi Fukayama & Tetsuo Ushiku
  406. University of Milano Bicocca, Monza, Italy
    Carlo Gambacorti-Passerini
  407. BGI-Shenzhen, Shenzhen, China
    Shengjie Gao, Yong Hou, Chang Li, Lin Li, Siliang Li, Xiaobo Li, Xinyue Li, Dongbing Liu, Xingmin Liu, Qiang Pan-Hammarström, Hong Su, Jian Wang, Kui Wu, Heng Xiong, Huanming Yang, Chen Ye, Xiuqing Zhang, Yong Zhou & Shida Zhu
  408. Department of Pathology, Oslo University Hospital Ulleval, Oslo, Norway
    Øystein Garred
  409. Center for Biomedical Informatics, Harvard Medical School, Boston, MA, USA
    Nils Gehlenborg
  410. Department Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain
    Josep L. L. Gelpi
  411. Office of Cancer Genomics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Daniela S. Gerhard
  412. Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Clarissa Gerhauser, Christoph Plass & Dieter Weichenhan
  413. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Jeffrey E. Gershenwald
  414. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Jeffrey E. Gershenwald
  415. Department of Computer Science, Yale University, New Haven, CT, USA
    Mark Gerstein & Fabio C. P. Navarro
  416. Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, USA
    Mark Gerstein, Sushant Kumar, Lucas Lochovsky, Shaoke Lou, Patrick D. McGillivray, Fabio C. P. Navarro, Leonidas Salichos & Jonathan Warrell
  417. Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA
    Mark Gerstein, Arif O. Harmanci, Sushant Kumar, Donghoon Lee, Shantao Li, Xiaotong Li, Lucas Lochovsky, Shaoke Lou, William Meyerson, Leonidas Salichos, Jonathan Warrell, Jing Zhang & Yan Zhang
  418. Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA
    Gad Getz & Paz Polak
  419. Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
    Gad Getz
  420. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ronald Ghossein, Dilip D. Giri, Christine A. Iacobuzio-Donahue, Jorge Reis-Filho & Victor Reuter
  421. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Nasra H. Giama, Catherine D. Moser & Lewis R. Roberts
  422. University of Sydney, Sydney, NSW, Australia
    Anthony J. Gill & James G. Kench
  423. University of Oxford, Oxford, UK
    Pelvender Gill, Freddie C. Hamdy, Katalin Karaszi, Adam Lambert, Luke Marsden, Clare Verrill & Paresh Vyas
  424. Department of Surgery, Academic Urology Group, University of Cambridge, Cambridge, UK
    Vincent J. Gnanapragasam
  425. Department of Medicine II, University of Würzburg, Wuerzburg, Germany
    Maria Elisabeth Goebler
  426. Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA
    Carmen Gomez
  427. Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain
    Abel Gonzalez-Perez
  428. Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA
    Dmitry A. Gordenin & Natalie Saini
  429. St. Thomas’s Hospital, London, UK
    James Gossage
  430. Osaka International Cancer Center, Osaka, Japan
    Kunihito Gotoh
  431. Department of Pathology, Skåne University Hospital, Lund University, Lund, Sweden
    Dorthe Grabau
  432. Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK
    Janet S. Graham
  433. National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
    Eric Green, Carolyn M. Hutter & Heidi J. Sofia
  434. Centre for Cancer Research, Victorian Comprehensive Cancer Centre, University of Melbourne, Melbourne, VIC, Australia
    Sean M. Grimmond
  435. Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA
    Robert L. Grossman
  436. German Center for Infection Research (DZIF), Partner Site Hamburg-Borstel-Lübeck-Riems, Hamburg, Germany
    Adam Grundhoff
  437. Bioinformatics Research Centre (BiRC), Aarhus University, Aarhus, Denmark
    Qianyun Guo, Asger Hobolth & Jakob Skou Pedersen
  438. Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi, Delhi, India
    Shailja Gupta & K. VijayRaghavan
  439. National Cancer Centre Singapore, Singapore, Singapore
    Jonathan Göke
  440. Brandeis University, Waltham, MA, USA
    James E. Haber
  441. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
    Faraz Hach
  442. Department of Internal Medicine, Stanford University, Stanford, CA, USA
    Mark P. Hamilton
  443. The University of Texas Health Science Center at Houston, Houston, TX, USA
    Leng Han, Yang Yang & Xuanping Zhang
  444. Imperial College NHS Trust, Imperial College, London, INY, UK
    George B. Hanna
  445. Senckenberg Institute of Pathology, University of Frankfurt Medical School, Frankfurt, Germany
    Martin Hansmann
  446. Department of Medicine, Division of Biomedical Informatics, UC San Diego School of Medicine, San Diego, CA, USA
    Olivier Harismendy
  447. Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center, Houston, TX, USA
    Arif O. Harmanci
  448. Oxford Nanopore Technologies, New York, NY, USA
    Eoghan Harrington & Sissel Juul
  449. Institute of Medical Science, University of Tokyo, Tokyo, Japan
    Takanori Hasegawa, Shuto Hayashi, Seiya Imoto, Mitsuhiro Komura, Satoru Miyano, Naoki Miyoshi, Kazuhiro Ohi, Eigo Shimizu, Yuichi Shiraishi, Hiroko Tanaka & Rui Yamaguchi
  450. Howard Hughes Medical Institute, University of California Santa Cruz, Santa Cruz, CA, USA
    David Haussler
  451. Wakayama Medical University, Wakayama, Japan
    Shinya Hayami, Masaki Ueno & Hiroki Yamaue
  452. Department of Internal Medicine, Division of Medical Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    D. Neil Hayes
  453. University of Tennessee Health Science Center for Cancer Research, Memphis, TN, USA
    D. Neil Hayes
  454. Department of Histopathology, Salford Royal NHS Foundation Trust, Salford, UK
    Stephen J. Hayes
  455. Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
    Stephen J. Hayes
  456. BIOPIC, ICG and College of Life Sciences, Peking University, Beijing, China
    Yao He & Zemin Zhang
  457. Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
    Yao He & Zemin Zhang
  458. Children’s Hospital of Philadelphia, Philadelphia, PA, USA
    Allison P. Heath
  459. Department of Bioinformatics and Computational Biology and Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Apurva M. Hegde, Yiling Lu & John N. Weinstein
  460. Karolinska Institute, Stockholm, Sweden
    Eva Hellstrom-Lindberg & Jesper Lagergren
  461. The Donnelly Centre, University of Toronto, Toronto, ON, Canada
    Mohamed Helmy & Jeffrey A. Wintersinger
  462. Department of Medical Genetics, College of Medicine, Hallym University, Chuncheon, South Korea
    Seong Gu Heo, Eun Pyo Hong & Ji Wan Park
  463. Department of Experimental and Health Sciences, Institute of Evolutionary Biology (UPF-CSIC), Universitat Pompeu Fabra, Barcelona, Spain
    José María Heredia-Genestar, Tomas Marques-Bonet & Arcadi Navarro
  464. Health Data Science Unit, University Clinics, Heidelberg, Germany
    Carl Herrmann
  465. Massachusetts General Hospital Center for Cancer Research, Charlestown, MA, USA
    Julian M. Hess & Yosef E. Maruvka
  466. Hokkaido University, Sapporo, Japan
    Satoshi Hirano & Toru Nakamura
  467. Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Nobuyoshi Hiraoka
  468. Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Katherine A. Hoadley & Tara J. Skelly
  469. Computational Biology, Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Jena, Germany
    Steve Hoffmann
  470. University of Melbourne Centre for Cancer Research, Melbourne, VIC, Australia
    Oliver Hofmann
  471. University of Nebraska Medical Center, Omaha, NE, USA
    Michael A. Hollingsworth & Sarah P. Thayer
  472. Syntekabio Inc, Daejeon, South Korea
    Jongwhi H. Hong
  473. Department of Pathology, Academic Medical Center, Amsterdam, AZ, The Netherlands
    Gerrit K. Hooijer
  474. China National GeneBank-Shenzhen, Shenzhen, China
    Yong Hou, Chang Li, Siliang Li, Xiaobo Li, Dongbing Liu, Xingmin Liu, Henk G. Stunnenberg, Hong Su, Kui Wu, Heng Xiong, Chen Ye & Shida Zhu
  475. Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Volker Hovestadt, Murat Iskar, Peter Lichter, Bernhard Radlwimmer & Marc Zapatka
  476. Division of Life Science and Applied Genomics Center, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China
    Taobo Hu, Yogesh Kumar, Eric Z. Ma, Zhenggang Wu & Hong Xue
  477. Icahn School of Medicine at Mount Sinai, New York, NY, USA
    Kuan-lin Huang
  478. Geneplus-Shenzhen, Shenzhen, China
    Yi Huang
  479. School of Computer Science and Technology, Xi’an Jiaotong University, Xi’an, China
    Yi Huang, Jiayin Wang, Xiao Xiao & Xuanping Zhang
  480. AbbVie, North Chicago, IL, USA
    Thomas J. Hudson
  481. Institute of Pathology, Charité – University Medicine Berlin, Berlin, Germany
    Michael Hummel & Dido Lenze
  482. Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, BC, Canada
    David Huntsman
  483. Edinburgh Royal Infirmary, Edinburgh, UK
    Ted R. Hupp
  484. Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany
    Matthew R. Huska, Julia Markowski & Roland F. Schwarz
  485. Department of Pediatric Immunology, Hematology and Oncology, University Hospital, Heidelberg, Germany
    Daniel Hübschmann
  486. German Cancer Research Center (DKFZ), Heidelberg, Germany
    Daniel Hübschmann, Christof von Kalle & Roland F. Schwarz
  487. Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany
    Daniel Hübschmann
  488. Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA
    Marcin Imielinski
  489. New York Genome Center, New York, NY, USA
    Marcin Imielinski & Xiaotong Yao
  490. Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    William B. Isaacs
  491. Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
    Shumpei Ishikawa, Hiroto Katoh & Daisuke Komura
  492. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA
    Michael Ittmann
  493. Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA
    Michael Ittmann
  494. Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA
    Michael Ittmann
  495. Technical University of Denmark, Lyngby, Denmark
    Jose M. G. Izarzugaza
  496. Department of Pathology, College of Medicine, Hanyang University, Seoul, South Korea
    Jocelyne Jacquemier, Hyung-Yong Kim & Gu Kong
  497. Academic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK
    Nigel B. Jamieson
  498. Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Songpa-gu, Seoul, South Korea
    Se Jin Jang & Hee Jin Lee
  499. Science Writer, Garrett Park, MD, USA
    Karine Jegalian
  500. International Cancer Genome Consortium (ICGC)/ICGC Accelerating Research in Genomic Oncology (ARGO) Secretariat, Ontario Institute for Cancer Research, Toronto, ON, Canada
    Jennifer L. Jennings
  501. University of Ljubljana, Ljubljana, Slovenia
    Lara Jerman
  502. Department of Public Health Sciences, University of Chicago, Chicago, IL, USA
    Yuan Ji
  503. Research Institute, NorthShore University HealthSystem, Evanston, IL, USA
    Yuan Ji
  504. Department for Biomedical Research, University of Bern, Bern, Switzerland
    Rory Johnson, Andrés Lanzós & Mark A. Rubin
  505. Centre of Genomics and Policy, McGill University and Génome Québec Innovation Centre, Montreal, QC, Canada
    Yann Joly, Bartha M. Knoppers, Mark Phillips & Adrian Thorogood
  506. Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Corbin D. Jones
  507. Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany
    David T. W. Jones, Marcel Kool & Stefan M. Pfister
  508. Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
    David T. W. Jones
  509. Cancer Research UK, London, UK
    Nic Jones & David Scott
  510. Indivumed GmbH, Hamburg, Germany
    Hartmut Juhl
  511. Genome Integration Data Center, Syntekabio, Inc, Daejeon, South Korea
    Jongsun Jung
  512. University Hospital Zurich, Zurich, Switzerland
    Andre Kahles, Kjong-Van Lehmann & Gunnar Rätsch
  513. Clinical Bioinformatics, Swiss Institute of Bioinformatics, Geneva, Switzerland
    Abdullah Kahraman
  514. Institute for Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland
    Abdullah Kahraman
  515. Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland
    Abdullah Kahraman & Christian von Mering
  516. MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, UK
    Vera B. Kaiser & Colin A. Semple
  517. Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    Beth Karlan
  518. Department of Biology, Bioinformatics Group, Division of Molecular Biology, Faculty of Science, University of Zagreb, Zagreb, Croatia
    Rosa Karlić
  519. Department for Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
    Dennis Karsch & Michael Kneba
  520. Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia
    Karin S. Kassahn
  521. Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
    Hitoshi Katai
  522. Department of Bioinformatics, Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan
    Mamoru Kato, Hirofumi Rokutan & Mihoko Saito-Adachi
  523. A.A. Kharkevich Institute of Information Transmission Problems, Moscow, Russia
    Marat D. Kazanov
  524. Oncology and Immunology, Dmitry Rogachev National Research Center of Pediatric Hematology, Moscow, Russia
    Marat D. Kazanov
  525. Skolkovo Institute of Science and Technology, Moscow, Russia
    Marat D. Kazanov
  526. Department of Surgery, The George Washington University, School of Medicine and Health Science, Washington, DC, USA
    Electron Kebebew
  527. Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Electron Kebebew
  528. Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia
    Richard F. Kefford
  529. MIT Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA
    Manolis Kellis
  530. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
    James G. Kench & Richard A. Scolyer
  531. Cholangiocarcinoma Screening and Care Program and Liver Fluke and Cholangiocarcinoma Research Centre, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
    Narong Khuntikeo
  532. Controlled Department and Institution, New York, NY, USA
    Ekta Khurana
  533. Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA
    Ekta Khurana & Alexander Martinez-Fundichely
  534. National Cancer Center, Gyeonggi, South Korea
    Hark Kyun Kim
  535. Department of Biochemistry, College of Medicine, Ewha Womans University, Seoul, South Korea
    Hyung-Lae Kim
  536. Health Sciences Department of Biomedical Informatics, University of California San Diego, La Jolla, CA, USA
    Jihoon Kim
  537. Research Core Center, National Cancer Centre Korea, Goyang-si, South Korea
    Jong K. Kim
  538. Department of Health Sciences and Technology, Sungkyunkwan University School of Medicine, Seoul, South Korea
    Youngwook Kim
  539. Samsung Genome Institute, Seoul, South Korea
    Youngwook Kim
  540. Breast Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center, Boston, MA, USA
    Tari A. King
  541. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Tari A. King & Samuel Singer
  542. Division of Breast Surgery, Brigham and Women’s Hospital, Boston, MA, USA
    Tari A. King
  543. Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA
    Leszek J. Klimczak
  544. Department of Clinical Science, University of Bergen, Bergen, Norway
    Stian Knappskog & Ola Myklebost
  545. Center For Medical Innovation, Seoul National University Hospital, Seoul, South Korea
    Youngil Koh
  546. Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
    Youngil Koh & Sung-Soo Yoon
  547. Institute of Computer Science, Polish Academy of Sciences, Warsawa, Poland
    Jan Komorowski
  548. Functional and Structural Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Marcel Kool, Andrey Korshunov, Michael Koscher, Stefan M. Pfister & Qi Wang
  549. Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, , National Institutes of Health, Bethesda, MD, USA
    Roelof Koster
  550. Institute for Medical Informatics Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
    Markus Kreuz & Markus Loeffler
  551. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Savitri Krishnamurthy
  552. Department of Hematology and Oncology, Georg-Augusts-University of Göttingen, Göttingen, Germany
    Dieter Kube & Lorenz H. P. Trümper
  553. Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany
    Ralf Küppers
  554. King’s College London and Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
    Jesper Lagergren
  555. Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA
    Peter W. Laird
  556. The University of Queensland Centre for Clinical Research, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia
    Sunil R. Lakhani & Peter T. Simpson
  557. Department of Pediatric Oncology and Hematology, University of Cologne, Cologne, Germany
    Pablo Landgraf
  558. University of Düsseldorf, Düsseldorf, Germany
    Pablo Landgraf & Guido Reifenberger
  559. Department of Pathology, Institut Jules Bordet, Brussels, Belgium
    Denis Larsimont
  560. Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
    Erik Larsson
  561. Children’s Medical Research Institute, Sydney, NSW, Australia
    Loretta M. S. Lau & Hilda A. Pickett
  562. ILSbio, LLC Biobank, Chestertown, MD, USA
    Xuan Le
  563. Division of Genetics and Genomics, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
    Eunjung Alice Lee
  564. Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea
    Jeong-Yeon Lee
  565. Department of Statistics, University of California Santa Cruz, Santa Cruz, CA, USA
    Juhee Lee
  566. National Genotyping Center, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
    Ming Ta Michael Lee
  567. Department of Vertebrate Genomics/Otto Warburg Laboratory Gene Regulation and Systems Biology of Cancer, Max Planck Institute for Molecular Genetics, Berlin, Germany
    Hans Lehrach, Hans-Jörg Warnatz & Marie-Laure Yaspo
  568. McGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada
    Louis Letourneau
  569. biobyte solutions GmbH, Heidelberg, Germany
    Ivica Letunic
  570. Gynecologic Oncology, NYU Laura and Isaac Perlmutter Cancer Center, New York University, New York, NY, USA
    Douglas A. Levine
  571. Division of Oncology, Stem Cell Biology Section, Washington University School of Medicine, St. Louis, MO, USA
    Tim Ley
  572. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Han Liang
  573. Harvard University, Cambridge, MA, USA
    Ziao Lin
  574. Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    W. M. Linehan
  575. University of Oslo, Oslo, Norway
    Ole Christian Lingjærde & Torill Sauer
  576. University of Toronto, Toronto, ON, Canada
    Fei-Fei Fei Liu, Quaid D. Morris, Ruian Shi, Shankar Vembu & Fan Yang
  577. Peking University, Beijing, China
    Fenglin Liu, Fan Zhang, Liangtao Zheng & Xiuqing Zheng
  578. School of Life Sciences, Peking University, Beijing, China
    Fenglin Liu
  579. Leidos Biomedical Research, Inc, McLean, VA, USA
    Jia Liu
  580. Hematology, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
    Armando Lopez-Guillermo
  581. Second Military Medical University, Shanghai, China
    Yong-Jie Lu & Hongwei Zhang
  582. Chinese Cancer Genome Consortium, Shenzhen, China
    Youyong Lu
  583. Department of Medical Oncology, Beijing Hospital, Beijing, China
    Youyong Lu
  584. Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China
    Youyong Lu & Rui Xing
  585. School of Medicine/School of Mathematics and Statistics, University of St. Andrews, St, Andrews, Fife, UK
    Andy G. Lynch
  586. Institute for Systems Biology, Seattle, WA, USA
    Lisa Lype, Sheila M. Reynolds & Ilya Shmulevich
  587. Department of Biochemistry and Molecular Biology, Faculty of Medicine, University Institute of Oncology-IUOPA, Oviedo, Spain
    Carlos López-Otín & Xose S. Puente
  588. Institut Bergonié, Bordeaux, France
    Gaetan MacGrogan
  589. Cancer Unit, MRC University of Cambridge, Cambridge, UK
    Shona MacRae
  590. Department of Pathology and Laboratory Medicine, Center for Personalized Medicine, Children’s Hospital Los Angeles, Los Angeles, CA, USA
    Dennis T. Maglinte
  591. John Curtin School of Medical Research, Canberra, ACT, Australia
    Graham J. Mann
  592. MVZ Department of Oncology, PraxisClinic am Johannisplatz, Leipzig, Germany
    Luisa Mantovani-Löffler
  593. Department of Information Technology, Ghent University, Ghent, Belgium
    Kathleen Marchal & Sergio Pulido-Tamayo
  594. Department of Plant Biotechnology and Bioinformatics, Ghent University, Ghent, Belgium
    Kathleen Marchal, Sergio Pulido-Tamayo & Lieven P. C. Verbeke
  595. Institute for Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH, USA
    Elaine R. Mardis
  596. Computational Biology Program, School of Medicine, Oregon Health and Science University, Portland, OR, USA
    Adam A. Margolin & Adam J. Struck
  597. Department of Surgery, Duke University, Durham, NC, USA
    Jeffrey Marks
  598. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
    Tomas Marques-Bonet, Jose I. Martin-Subero, Arcadi Navarro, David Torrents & Alfonso Valencia
  599. Institut Català de Paleontologia Miquel Crusafont, Universitat Autònoma de Barcelona, Barcelona, Spain
    Tomas Marques-Bonet
  600. University of Glasgow, Glasgow, UK
    Sancha Martin & Ke Yuan
  601. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    Jose I. Martin-Subero
  602. Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA
    R. Jay Mashl
  603. Department of Surgery and Cancer, Imperial College, London, INY, UK
    Erik Mayer
  604. Applications Department, Oxford Nanopore Technologies, Oxford, UK
    Simon Mayes & Daniel J. Turner
  605. Department of Obstetrics, Gynecology and Reproductive Services, University of California San Francisco, San Francisco, CA, USA
    Karen McCune & Karen Smith-McCune
  606. Department of Biochemistry and Molecular Medicine, University California at Davis, Sacramento, CA, USA
    John D. McPherson
  607. STTARR Innovation Facility, Princess Margaret Cancer Centre, Toronto, ON, Canada
    Alice Meng
  608. Discipline of Surgery, Western Sydney University, Penrith, NSW, Australia
    Neil D. Merrett
  609. Yale School of Medicine, Yale University, New Haven, CT, USA
    William Meyerson
  610. Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Piotr A. Mieczkowski, Joel S. Parker, Charles M. Perou, Donghui Tan, Umadevi Veluvolu & Matthew D. Wilkerson
  611. Departments of Neurology and Neurosurgery, Henry Ford Hospital, Detroit, MI, USA
    Tom Mikkelsen
  612. Precision Oncology, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
    Gordon B. Mills
  613. Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Sarah Minner, Guido Sauter & Ronald Simon
  614. Department of Health Sciences, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
    Shinichi Mizuno
  615. Heidelberg Academy of Sciences and Humanities, Heidelberg, Germany
    Fruzsina Molnár-Gábor
  616. Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia
    Carl Morrison, Karin A. Oien, Chawalit Pairojkul, Paul M. Waring & Marc J. van de Vijver
  617. Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY, USA
    Carl Morrison
  618. Department of Computer Science, University of Helsinki, Helsinki, Finland
    Ville Mustonen
  619. Institute of Biotechnology, University of Helsinki, Helsinki, Finland
    Ville Mustonen
  620. Organismal and Evolutionary Biology Research Programme, University of Helsinki, Helsinki, Finland
    Ville Mustonen
  621. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, St. Louis, MO, USA
    David Mutch
  622. Penrose St. Francis Health Services, Colorado Springs, CO, USA
    Jerome Myers
  623. Institute of Pathology, Ulm University and University Hospital of Ulm, Ulm, Germany
    Peter Möller
  624. National Cancer Center, Tokyo, Japan
    Hitoshi Nakagama
  625. Genome Institute of Singapore, Singapore, Singapore
    Tannistha Nandi & Patrick Tan
  626. 32Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA
    Fabio C. P. Navarro
  627. German Cancer Aid, Bonn, Germany
    Gerd Nettekoven & Laura Planko
  628. Programme in Cancer and Stem Cell Biology, Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore
    Alvin Wei Tian Ng
  629. The Chinese University of Hong Kong, Shatin, NT, Hong Kong, China
    Anthony Ng
  630. Fourth Military Medical University, Shaanxi, China
    Yongzhan Nie
  631. The University of Cambridge School of Clinical Medicine, Cambridge, UK
    Serena Nik-Zainal
  632. St. Jude Children’s Research Hospital, Memphis, TN, USA
    Paul A. Northcott
  633. University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada
    Faiyaz Notta & Ming Tsao
  634. Center for Biomolecular Science and Engineering, University of California Santa Cruz, Santa Cruz, CA, USA
    Brian D. O’Connor
  635. Department of Medicine, University of Chicago, Chicago, IL, USA
    Peter O’Donnell
  636. Department of Neurology, Mayo Clinic, Rochester, MN, USA
    Brian Patrick O’Neill
  637. Cambridge Oesophagogastric Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
    J. Robert O’Neill
  638. Department of Computer Science, Carleton College, Northfield, MN, USA
    Layla Oesper
  639. Institute of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
    Karin A. Oien
  640. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA
    Akinyemi I. Ojesina
  641. HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA
    Akinyemi I. Ojesina
  642. O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA
    Akinyemi I. Ojesina
  643. Department of Pathology, Keio University School of Medicine, Tokyo, Japan
    Hidenori Ojima
  644. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
    Takuji Okusaka
  645. Sage Bionetworks, Seattle, WA, USA
    Larsson Omberg
  646. Lymphoma Genomic Translational Research Laboratory, National Cancer Centre, Singapore, Singapore
    Choon Kiat Ong
  647. Department of Clinical Pathology, Robert-Bosch-Hospital, Stuttgart, Germany
    German Ott
  648. Department of Cell and Systems Biology, University of Toronto, Toronto, ON, Canada
    B. F. Francis Ouellette
  649. Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
    Qiang Pan-Hammarström
  650. Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, Gyeonggi, South Korea
    Joong-Won Park
  651. Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
    Keunchil Park
  652. Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University School of Medicine, Seoul, South Korea
    Keunchil Park
  653. Cheonan Industry-Academic Collaboration Foundation, Sangmyung University, Cheonan, South Korea
    Kiejung Park
  654. NYU Langone Medical Center, New York, NY, USA
    Harvey Pass
  655. Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA
    Nathan A. Pennell
  656. Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA
    Marc D. Perry
  657. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
    Gloria M. Petersen
  658. Helen F. Graham Cancer Center at Christiana Care Health Systems, Newark, DE, USA
    Nicholas Petrelli
  659. Heidelberg University Hospital, Heidelberg, Germany
    Stefan M. Pfister
  660. CSRA Incorporated, Fairfax, VA, USA
    Todd D. Pihl
  661. Research Department of Pathology, University College London Cancer Institute, London, UK
    Nischalan Pillay
  662. Department of Research Oncology, Guy’s Hospital, King’s Health Partners AHSC, King’s College London School of Medicine, London, UK
    Sarah Pinder
  663. Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia
    Andreia V. Pinho
  664. University Hospital of Minjoz, INSERM UMR 1098, Besançon, France
    Xavier Pivot
  665. Spanish National Cancer Research Centre, Madrid, Spain
    Tirso Pons
  666. Center of Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania
    Irinel Popescu
  667. Cureline, Inc, South San Francisco, CA, USA
    Olga Potapova
  668. St. Luke’s Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK
    Shaun R. Preston
  669. Cambridge Breast Unit, Addenbrooke’s Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge, UK
    Elena Provenzano
  670. East of Scotland Breast Service, Ninewells Hospital, Aberdeen, UK
    Colin A. Purdie
  671. Department of Genetics, Microbiology and Statistics, University of Barcelona, IRSJD, IBUB, Barcelona, Spain
    Raquel Rabionet
  672. Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA
    Janet S. Rader
  673. Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA
    Suresh Ramalingam
  674. Department of Computer Science, Princeton University, Princeton, NJ, USA
    Benjamin J. Raphael & Matthew A. Reyna
  675. Vanderbilt Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA
    W. Kimryn Rathmell
  676. Ohio State University College of Medicine and Arthur G. James Comprehensive Cancer Center, Columbus, OH, USA
    Matthew Ringel
  677. Department of Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan
    Yasushi Rino
  678. Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany
    Karsten Rippe
  679. Research Computing Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Jeffrey Roach
  680. School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, WA, USA
    Steven A. Roberts
  681. Finsen Laboratory and Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
    F. Germán Rodríguez-González, Nikos Sidiropoulos & Joachim Weischenfeldt
  682. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
    Michael H. A. Roehrl & Stefano Serra
  683. Department of Pathology, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Michael H. A. Roehrl
  684. University Hospital Giessen, Pediatric Hematology and Oncology, Giessen, Germany
    Marius Rohde
  685. Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France
    Gilles Romieu
  686. Institute of Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany
    Philip C. Rosenstiel & Markus B. Schilhabel
  687. Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany
    Andreas Rosenwald
  688. Department of Urology, North Bristol NHS Trust, Bristol, UK
    Edward W. Rowe
  689. SingHealth, Duke-NUS Institute of Precision Medicine, National Heart Centre Singapore, Singapore, Singapore
    Steven G. Rozen, Patrick Tan & Bin Tean Teh
  690. Department of Computer Science, University of Toronto, Toronto, ON, Canada
    Yulia Rubanova, Jared T. Simpson & Jeffrey A. Wintersinger
  691. Bern Center for Precision Medicine, University Hospital of Bern, University of Bern, Bern, Switzerland
    Mark A. Rubin
  692. Englander Institute for Precision Medicine, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY, USA
    Mark A. Rubin
  693. Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
    Mark A. Rubin
  694. Pathology and Laboratory, Weill Cornell Medical College, New York, NY, USA
    Mark A. Rubin
  695. Vall d’Hebron Institute of Oncology: VHIO, Barcelona, Spain
    Carlota Rubio-Perez
  696. General and Hepatobiliary-Biliary Surgery, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy
    Andrea Ruzzenente
  697. National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
    Radhakrishnan Sabarinathan
  698. Indiana University, Bloomington, IN, USA
    S. Cenk Sahinalp
  699. Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium
    Roberto Salgado
  700. Analytical Biological Services, Inc, Wilmington, DE, USA
    Charles Saller
  701. Sydney Medical School, University of Sydney, Sydney, NSW, Australia
    Jaswinder S. Samra & Richard A. Scolyer
  702. cBio Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Chris Sander & Ciyue Shen
  703. Department of Cell Biology, Harvard Medical School, Boston, MA, USA
    Chris Sander & Ciyue Shen
  704. Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India
    Rajiv Sarin
  705. School of Environmental and Life Sciences, Faculty of Science, The University of Newcastle, Ourimbah, NSW, Australia
    Christopher J. Scarlett
  706. Department of Dermatology, University Hospital of Essen, Essen, Germany
    Dirk Schadendorf
  707. Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Matthias Schlesner
  708. Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany
    Thorsten Schlomm & Joachim Weischenfeldt
  709. Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Thorsten Schlomm
  710. Department of General Internal Medicine, University of Kiel, Kiel, Germany
    Stefan Schreiber
  711. German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany
    Roland F. Schwarz
  712. Cancer Research Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Ralph Scully
  713. University of Pittsburgh, Pittsburgh, PA, USA
    Raja Seethala
  714. Department of Ophthalmology and Ocular Genomics Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA
    Ayellet V. Segre
  715. Center for Psychiatric Genetics, NorthShore University HealthSystem, Evanston, IL, USA
    Subhajit Sengupta
  716. Van Andel Research Institute, Grand Rapids, MI, USA
    Hui Shen & Wanding Zhou
  717. Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan
    Tatsuhiro Shibata, Hirokazu Taniguchi & Tomoko Urushidate
  718. Japan Agency for Medical Research and Development, Tokyo, Japan
    Kiyo Shimizu & Takashi Yugawa
  719. Korea University, Seoul, South Korea
    Seung Jun Shin & Stefan G. Stark
  720. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, USA
    Craig Shriver
  721. Human Genetics, University of Kiel, Kiel, Germany
    Reiner Siebert
  722. Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Sabina Signoretti
  723. Oregon Health and Science University, Portland, OR, USA
    Jaclyn Smith
  724. Center for RNA Interference and Noncoding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Anil K. Sood
  725. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Anil K. Sood
  726. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Anil K. Sood
  727. University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
    Sharmila Sothi
  728. Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, GA, The Netherlands
    Paul N. Span
  729. Institute for Genomics and Systems Biology, University of Chicago, Chicago, IL, USA
    Jonathan Spring
  730. Clinic for Hematology and Oncology, St.-Antonius-Hospital, Eschweiler, Germany
    Peter Staib
  731. Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Stefan G. Stark
  732. University of Iceland, Reykjavik, Iceland
    Ólafur Andri Stefánsson
  733. Division of Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Oliver Stegle
  734. Dundee Cancer Centre, Ninewells Hospital, Dundee, UK
    Alasdair Stenhouse & Alastair M. Thompson
  735. Department for Internal Medicine III, University of Ulm and University Hospital of Ulm, Ulm, Germany
    Stephan Stilgenbauer
  736. Institut Curie, INSERM Unit 830, Paris, France
    Henk G. Stunnenberg & Anne Vincent-Salomon
  737. Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan
    Akihiro Suzuki
  738. Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, GA, The Netherlands
    Fred Sweep
  739. Division of Cancer Genome Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Holger Sültmann
  740. Department of General Surgery, Singapore General Hospital, Singapore, Singapore
    Benita Kiat Tee Tan
  741. Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
    Patrick Tan & Bin Tean Teh
  742. Department of Medical and Clinical Genetics, Genome-Scale Biology Research Program, University of Helsinki, Helsinki, Finland
    Tomas J. Tanskanen
  743. East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
    Patrick Tarpey
  744. Irving Institute for Cancer Dynamics, Columbia University, New York, NY, USA
    Simon Tavaré
  745. Institute of Molecular and Cell Biology, Singapore, Singapore
    Bin Tean Teh
  746. Laboratory of Cancer Epigenome, Division of Medical Science, National Cancer Centre Singapore, Singapore, Singapore
    Bin Tean Teh
  747. Universite Lyon, INCa-Synergie, Centre Léon Bérard, Lyon, France
    Gilles Thomas
  748. Department of Urology, Mayo Clinic, Rochester, MN, USA
    R. Houston Thompson
  749. Royal National Orthopaedic Hospital - Stanmore, Stanmore, Middlesex, UK
    Roberto Tirabosco
  750. Department of Biochemistry, Genetics and Immunology, University of Vigo, Vigo, Spain
    Marta Tojo
  751. Giovanni Paolo II / I.R.C.C.S. Cancer Institute, Bari, BA, Italy
    Stefania Tommasi
  752. Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Umut H. Toprak
  753. Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy, Rome, Italy
    Giampaolo Tortora
  754. University of Verona, Verona, Italy
    Giampaolo Tortora
  755. Centre National de Génotypage, CEA - Institute de Génomique, Evry, France
    Jörg Tost
  756. CAPHRI Research School, Maastricht University, Maastricht, ER, The Netherlands
    David Townend
  757. Department of Biopathology, Centre Léon Bérard, Lyon, France
    Isabelle Treilleux
  758. Université Claude Bernard Lyon 1, Villeurbanne, France
    Isabelle Treilleux
  759. Core Research for Evolutional Science and Technology (CREST), JST, Tokyo, Japan
    Tatsuhiko Tsunoda
  760. Department of Biological Sciences, Laboratory for Medical Science Mathematics, Graduate School of Science, University of Tokyo, Yokohama, Japan
    Tatsuhiko Tsunoda
  761. Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
    Tatsuhiko Tsunoda
  762. Cancer Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK
    Jose M. C. Tubio
  763. University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
    Olga Tucker
  764. Centre for Cancer Research and Cell Biology, Queen’s University, Belfast, UK
    Richard Turkington
  765. Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Naoto T. Ueno
  766. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Christopher Umbricht
  767. Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden
    Husen M. Umer
  768. School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
    Timothy J. Underwood
  769. Department of Gene Technology, Tallinn University of Technology, Tallinn, Estonia
    Liis Uusküla-Reimand
  770. Genetics and Genome Biology Program, SickKids Research Institute, The Hospital for Sick Children, Toronto, ON, Canada
    Liis Uusküla-Reimand
  771. Departments of Neurosurgery and Hematology and Medical Oncology, Winship Cancer Institute and School of Medicine, Emory University, Atlanta, GA, USA
    Erwin G. Van Meir
  772. Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
    Miguel Vazquez
  773. Argmix Consulting, North Vancouver, BC, Canada
    Shankar Vembu
  774. Department of Information Technology, Ghent University, Interuniversitair Micro-Electronica Centrum (IMEC), Ghent, Belgium
    Lieven P. C. Verbeke
  775. Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford, Oxford, UK
    Clare Verrill
  776. Institute of Mathematics and Computer Science, University of Latvia, Riga, LV, Latvia
    Juris Viksna
  777. Discipline of Pathology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia
    Ricardo E. Vilain
  778. Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, University of Cambridge, Cambridge, UK
    Ignacio Vázquez-García
  779. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ignacio Vázquez-García & Venkata D. Yellapantula
  780. Department of Statistics, Columbia University, New York, NY, USA
    Ignacio Vázquez-García
  781. Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
    Claes Wadelius
  782. School of Electronic and Information Engineering, Xi’an Jiaotong University, Xi’an, China
    Jiayin Wang & Kai Ye
  783. Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
    Anne Y. Warren
  784. Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK
    David C. Wedge
  785. Georgia Regents University Cancer Center, Augusta, GA, USA
    Paul Weinberger
  786. Wythenshawe Hospital, Manchester, UK
    Ian Welch
  787. Department of Genetics, Washington University School of Medicine, St.Louis, MO, USA
    Michael C. Wendl
  788. Department of Biological Oceanography, Leibniz Institute of Baltic Sea Research, Rostock, Germany
    Johannes Werner
  789. Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK
    Justin P. Whalley
  790. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
    David A. Wheeler
  791. Thoracic Oncology Laboratory, Mayo Clinic, Rochester, MN, USA
    Dennis Wigle
  792. Institute for Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH, USA
    Richard K. Wilson
  793. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, USA
    Boris Winterhoff
  794. International Institute for Molecular Oncology, Poznań, Poland
    Maciej Wiznerowicz
  795. Poznan University of Medical Sciences, Poznań, Poland
    Maciej Wiznerowicz
  796. Genomics and Proteomics Core Facility High Throughput Sequencing Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany
    Stephan Wolf
  797. NCCS-VARI Translational Research Laboratory, National Cancer Centre Singapore, Singapore, Singapore
    Bernice H. Wong
  798. Edison Family Center for Genome Sciences and Systems Biology, Washington University, St. Louis, MO, USA
    Winghing Wong
  799. MRC-University of Glasgow Centre for Virus Research, Glasgow, UK
    Derek W. Wright
  800. Department of Medical Informatics and Clinical Epidemiology, Division of Bioinformatics and Computational Biology, OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
    Guanming Wu
  801. School of Electronic Information and Communications, Huazhong University of Science and Technology, Wuhan, China
    Tian Xia
  802. Department of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD, USA
    Yanxun Xu
  803. Department of Cancer Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan
    Shinichi Yachida
  804. Institute of Computer Science, Heidelberg University, Heidelberg, Germany
    Sergei Yakneen
  805. School of Mathematics and Statistics, University of Sydney, Sydney, NSW, Australia
    Jean Y. Yang
  806. Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA
    Lixing Yang
  807. Department of Human Genetics, University of Chicago, Chicago, IL, USA
    Lixing Yang
  808. Tri-Institutional PhD Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY, USA
    Xiaotong Yao
  809. The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, China
    Kai Ye
  810. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, China
    Jun Yu
  811. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Kaixian Yu & Hongtu Zhu
  812. Duke-NUS Medical School, Singapore, Singapore
    Willie Yu
  813. Department of Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
    Yingyan Yu
  814. School of Computing Science, University of Glasgow, Glasgow, UK
    Ke Yuan
  815. Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway
    Olga Zaikova
  816. Eastern Clinical School, Monash University, Melbourne, VIC, Australia
    Nikolajs Zeps
  817. Epworth HealthCare, Richmond, VIC, Australia
    Nikolajs Zeps
  818. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
    Cheng-Zhong Zhang
  819. Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA
    Yan Zhang
  820. The Ohio State University Comprehensive Cancer Center (OSUCCC – James), Columbus, OH, USA
    Yan Zhang
  821. The University of Texas School of Biomedical Informatics (SBMI) at Houston, Houston, TX, USA
    Zhongming Zhao
  822. Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Hongtu Zhu
  823. Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
    Lihua Zou
  824. Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia
    Anna deFazio
  825. Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, GD, The Netherlands
    Carolien H. M. van Deurzen
  826. Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, CX, The Netherlands
    L. van’t Veer
  827. Institute of Molecular Life Sciences and Swiss Institute of Bioinformatics, University of Zurich, Zurich, Switzerland
    Christian von Mering

Authors

  1. Bernardo Rodriguez-Martin
    You can also search for this author inPubMed Google Scholar
  2. Eva G. Alvarez
    You can also search for this author inPubMed Google Scholar
  3. Adrian Baez-Ortega
    You can also search for this author inPubMed Google Scholar
  4. Jorge Zamora
    You can also search for this author inPubMed Google Scholar
  5. Fran Supek
    You can also search for this author inPubMed Google Scholar
  6. Jonas Demeulemeester
    You can also search for this author inPubMed Google Scholar
  7. Martin Santamarina
    You can also search for this author inPubMed Google Scholar
  8. Young Seok Ju
    You can also search for this author inPubMed Google Scholar
  9. Javier Temes
    You can also search for this author inPubMed Google Scholar
  10. Daniel Garcia-Souto
    You can also search for this author inPubMed Google Scholar
  11. Harald Detering
    You can also search for this author inPubMed Google Scholar
  12. Yilong Li
    You can also search for this author inPubMed Google Scholar
  13. Jorge Rodriguez-Castro
    You can also search for this author inPubMed Google Scholar
  14. Ana Dueso-Barroso
    You can also search for this author inPubMed Google Scholar
  15. Alicia L. Bruzos
    You can also search for this author inPubMed Google Scholar
  16. Stefan C. Dentro
    You can also search for this author inPubMed Google Scholar
  17. Miguel G. Blanco
    You can also search for this author inPubMed Google Scholar
  18. Gianmarco Contino
    You can also search for this author inPubMed Google Scholar
  19. Daniel Ardeljan
    You can also search for this author inPubMed Google Scholar
  20. Marta Tojo
    You can also search for this author inPubMed Google Scholar
  21. Nicola D. Roberts
    You can also search for this author inPubMed Google Scholar
  22. Sonia Zumalave
    You can also search for this author inPubMed Google Scholar
  23. Paul A. Edwards
    You can also search for this author inPubMed Google Scholar
  24. Joachim Weischenfeldt
    You can also search for this author inPubMed Google Scholar
  25. Montserrat Puiggròs
    You can also search for this author inPubMed Google Scholar
  26. Zechen Chong
    You can also search for this author inPubMed Google Scholar
  27. Ken Chen
    You can also search for this author inPubMed Google Scholar
  28. Eunjung Alice Lee
    You can also search for this author inPubMed Google Scholar
  29. Jeremiah A. Wala
    You can also search for this author inPubMed Google Scholar
  30. Keiran M. Raine
    You can also search for this author inPubMed Google Scholar
  31. Adam Butler
    You can also search for this author inPubMed Google Scholar
  32. Sebastian M. Waszak
    You can also search for this author inPubMed Google Scholar
  33. Fabio C. P. Navarro
    You can also search for this author inPubMed Google Scholar
  34. Steven E. Schumacher
    You can also search for this author inPubMed Google Scholar
  35. Jean Monlong
    You can also search for this author inPubMed Google Scholar
  36. Francesco Maura
    You can also search for this author inPubMed Google Scholar
  37. Niccolo Bolli
    You can also search for this author inPubMed Google Scholar
  38. Guillaume Bourque
    You can also search for this author inPubMed Google Scholar
  39. Mark Gerstein
    You can also search for this author inPubMed Google Scholar
  40. Peter J. Park
    You can also search for this author inPubMed Google Scholar
  41. David C. Wedge
    You can also search for this author inPubMed Google Scholar
  42. Rameen Beroukhim
    You can also search for this author inPubMed Google Scholar
  43. David Torrents
    You can also search for this author inPubMed Google Scholar
  44. Jan O. Korbel
    You can also search for this author inPubMed Google Scholar
  45. Iñigo Martincorena
    You can also search for this author inPubMed Google Scholar
  46. Rebecca C. Fitzgerald
    You can also search for this author inPubMed Google Scholar
  47. Peter Van Loo
    You can also search for this author inPubMed Google Scholar
  48. Haig H. Kazazian
    You can also search for this author inPubMed Google Scholar
  49. Kathleen H. Burns
    You can also search for this author inPubMed Google Scholar
  50. Peter J. Campbell
    You can also search for this author inPubMed Google Scholar
  51. Jose M. C. Tubio
    You can also search for this author inPubMed Google Scholar

Consortia

PCAWG Structural Variation Working Group

PCAWG Consortium

Corresponding authors

Correspondence toPeter J. Campbell or Jose M. C. Tubio.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Rodriguez-Martin, B., Alvarez, E.G., Baez-Ortega, A. et al. Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition.Nat Genet 55, 1080 (2023). https://doi.org/10.1038/s41588-023-01319-9

Download citation